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Abbreviations  
AMD     Age dependent Macula Degeneration 
AP-1     activator protein 1 
ATP     adenosine triphosphat 
CHIP     carboxyl-terminus of Hsp70 interacting protein 
CO     carbon monoxide 
FDA     US Food and Drug Administration 
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HIF-1     hypoxia inducing factor-1 
HIP     Hsp70 interacting protein 
HNE     4-Hydroxy-2-nonenal 
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Hsp     heat shock protein 
Keap-1     Kelch-like ECH-associated protein 1 
MAPK     mitogen activated protein kinase 
MDA     malondialdehyde 
NF-κB nuclear factor kappa-light-chain-enhancer of activated B cells 
NLS     nuclear localization sequence 
Nrf-2     nuclear factor erythroid 2-related factor 2 
PI3K     phosphoinositol-3- kinase 
PKC     protein kinase C 
RISC     RNA-induced silencing complex 
ROS     reactive oxygen species 
RNS     reactive nitrogen species 
SOD     superoxide dismutase 
USP     ubiquitin specific protease 
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1. Introduction 
1.1 Protein homeostasis – proteostasis 
Mammalian cells express about 10000 different proteins which are synthesized as 
linear, unfolded amino acid sequences on ribosomes. To gain the typical protein 
functionality it is necessary that these linear sequences are folded into their native state, 
comprising their three-dimensional structure. The individual folding pattern is partly 
predefined by the amino acid sequence. 20-30% of total proteins in mammalian cells 
have inherently lost their three dimensional order and rely on additional binding 
partners to adopt a conformational state [1]. Due to the possibility that one protein can 
take on more than one conformation, the protein folding process possesses high 
complexity. In search of the right protein conformation (the native state), exhibiting a 
thermodynamically stable order with low free energy-surfaces, it comes to folding 
intermediates (occurs for about 90% of all cellular proteins) [2]. Due to free 
hydrophobic amino acids, folding intermediates tend to build rapidly compact globular 
protein structures, which are not leading to the native protein structure. Most of these 
unwanted globular protein structures can be defined as misfolded proteins or partially 
folded proteins. To bring them into the right conformation, there is the need of 
molecular chaperones, which help to overcome some thermodynamic barriers [3]. Since 
partially folded or misfolded proteins exhibit access to hydrophobic residues, they tend 
to accumulate and form aggregates [4].  
The prevention of protein misfolding and protein aggregation and maintaining the 
native protein structure, respectively protein functionality, is the definition of protein 
homeostasis (proteostasis). To cope with this challenge the proteostasis network 
comprises about 800 proteins, segmented into 200 chaperones and co-chaperones, that 
maintain folding, refolding and stabilization of proteins and 600 ubiquitin-proteasomal 
and autophagy components, which are responsible for the degradation of unfoldeable 
proteins and protein aggregates [5].  
1.2 The proteasomal system 
Maintenance of protein homeostasis is an essential part of keeping up cell functionality 
and cell survival [6]. As it was mentioned, unfolded and unfunctional proteins become 
refolded by molecular chaperones to regain their functionality. However, due to several 
Introduction 
_____________________________________________________________________________ 
5 
 
possible modifications, proteins become resistant to a refolding process. To cope with 
that challenge, the cell has installed two systems to degrade irreversibly misfolded 
proteins: autophagy and the ubiquitin-proteasomal system (UPS) [7]. Whereas 
autophagy is mostly responsible to store and sequester potentially toxic protein 
aggregates [8], the UPS is responsible for the highly regulated degradation of most 
cytosolic proteins and proteins that are located in the nucleus and the endoplasmatic 
reticulum (ER) [9-11]. 
1.2.1 The 20S core proteasome 
The proteasome is a cylindric shaped, multi-catalytic protease with a molecular mass of 
about 700kDa. The core structure of this complex is called the 20S proteasome. Due to 
the fact that the 20S proteasome builds the core structure for all existing proteasomal 
forms, it is involved in a multitude of cellular processes, such as life span regulation of 
proteins [12,13], protein quality control [14,15], cell cycle regulation [16], 
carcinogenesis [17,18], DNA-repair [19,20], gene-expression [21,22], stress response 
[23,24], the immune response [25,26] and degradation of oxidized proteins [27,28].  
The 20S proteasome consists of two α-rings and two β-rings, forming a barrel, whereas 
the two β-rings are arranged in the middle and the two α-rings form the closure on each 
side of the barrel (Fig.1) [29]. These αββα ring-construction forms three chambers 
inside the 20S proteasome: two ante- or forechambers, build of one α-ring and one β-
ring and a core chamber, which is build by the two inner β-rings [30]. Every α/β-ring 
consists of seven α- or β- subunits (α1-7/β1-7). While the α-subunits are responsible for 
substrate access and binding of the several proteasomal regulators, the β-subunits form 
the proteolytic center of the 20S core structure. The main task of β-subunits is to 
degrade the large variety of polypeptides and proteins which pass the α-ring. Therefore, 
three of the seven subunits have a threonine protease activity. The β1 subunits 
preferentially cleave after acidic residues (peptidyl-glutamyl-peptide-hydrolase activity 
or caspase like activity), the β2 subunit displays a trypsin-like activity (cleavage after 
basic amino acids) and β5 acts as a chymotrypsin-like protease (cleavage after neutral 
amino acids) [31,32].  
Access into the proteolytic center of the proteasome is only possible if the substrate 
interacts with the outer α-subunits, followed by a conformational change, unlocking a 
gate that is formed by N-terminal ends of the α2, α3 and α4 subunits. It was observed that 
detergents like SDS or hydrophobic molecules have the ability to open the closed 
conformation of the 20S proteasome, enhancing its proteolytic activity. Thus, substrates 
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of the 20S proteasome have to be unfolded, (modified) proteins, exhibiting their 
hydrophobic structure [31,33,34].  
1.2.2 The 26S proteasome 
Since proteolysis catalyzed by the proteasome comprises not alone unfolded and 
damaged proteins, but rather a large spectrum of short lived, regulatory, onco- and 
structural proteins [35], the 20S proteasome builds a complex with two 19S proteasome 
regulators (which is also called “PA700”). These two regulators bind to each side (to 
each α-ring) of the “20S cylinder”, forming the 26S proteasome (Fig. 1). In total the 
20S proteasome and the two 19S regulators reaching a protein mass of about 2MDa 
[31,36]. The 19S regulator forms a ring shaped base, which builds the connection to the 
α-rings of the 20S proteasome and a lid structure, regulating the entrance of 
polyubiquitinated substrates [37]. The ring-shaped footing of the 19S regulator is made 
out of 6 different Regulatory particle of triple ATPase (Rpt) - and 4 different Regulatory 
particle of non-ATPase (Rpn) subunits (Rpt1-6, Rpn1-2, Rpn10 and Rpn13). The base of 
the 19S proteasome has three important functions: (i) recognition of ubiquitin-tagged 
substrates, (ii) protein unfolding and (iii) opening of the translocation-channel in the α-
ring [37]. All 6 Rpt subunits and Rpn1/2 are involved in protein unfolding and the gate 
opening process. Recognition and binding of polyubiquitinated proteins is conducted by 
Rpn10 and Rpn 13, which are closely located to the lid structure. The lid consist of nine 
Rpn subunits (Rpn 3,5-9,11,12,15), whereas Rpn 11 functions as a deubiquitinating enzyme, 
cleaving polyubiquitin chains at the proximal site of proteasomal substrates [38]. It is 
possible that the 19S regulator is also associated to external deubiquitinating enzymes, 
like Usp14 or Uch37. Some of them, for example Usp14 (in yeast: Ubp6), become 
activated by a lack of free available monoubiquitin, accelerating deubiquitination of 
proteasomal substrates and altering proteasomal function [39].  
For the sake of completeness, it should be mentioned shortly that there are also two 
other common forms of the proteasome. Besides the 19S regulator the proteasome is 
also able to build a complex with the 11S proteasome regulator (also called PA 28). If 
the 11S regulator binds to both sides of the 20S cylinder and the normal β-subunits (β1, 
β2, β5) are substituted by inducible β-subunits (β1i, β2i, β5i), there is talk of the 
immunoproteasome [40]. Thus, cytokines like IFN-γ or TNF-α induces synthesis and 
activity of these inducible β-subunits, which leads together with the 11S regulator to a 
spectrum of produced peptides that are associated with MHC class 1 antigen 
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presentation [41]. Is the 20S proteasome bound to one 11S regulator on the one side and 
to a 19S regulator on the other side, arises the hybrid proteasome. Although, the 
function of the hybrid proteasome is not fully understood, it is suggested that it also 
participates in antigen processing, since it was demonstrated that the activity of the 
hybrid proteasome is also stimulated by IFN- γ. Due to the incapacity of the 11S 
regulator to degrade folded proteins, it is possible that the 19S regulator of the hybrid 
proteasome is responsible for the ATP-dependent unfolding process and the 11S 
regulator take care for the production of MHC-1 related peptides [42]. 
 
 
Figure 1: The ubiquitin proteasomal system 
The figure depicts the several kinds of cellular proteasomes and the 
schematic mechanism of protein-ubiquitination ( [43] modified). 
 
1.3 Ubiquitin and the ubiquitination process 
As it was mentioned, most proteins have to be polyubiquitinated for degradation by the 
26S proteasome. A chain of at least four ubiquitin molecules is required to mark a 
protein for proteolysis by the 26S proteasome. 
1.3.1 Ubiquitin 
Ubiquitin is a highly conserved, small protein consisting of 76 amino acids [44]. Several 
consisting amino acids have important functions for the ubiquitination process. The C-
terminal glycine (G76) of ubiquitin is essential for the most common way to attach the 
first ubiquitin moiety to an ε-amino group of a lysine residue of its substrate by forming 
an isopeptide bond [45]. It is also possible, that ubiquitin binds to the N-terminal 
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residue of a peptide, preparing a linear polyubiquitin chain or there is a generation of 
ester/thioester bonds by conjugation with a cystein, serine or threonine residue [46]. 
Furthermore, ubiquitin contains several lysine residues which are necessary for the 
formation of polyubiquitin chains. In total the protein sequence of ubiquitin possesses 
five lysine (K) residues – K6, K27, K29, K48 and K63. In dependency of the involved 
lysine residue, a polyubiquitin-chain is able to fulfill different functions. Polyubiquitin 
chains that are based on K63-linkages act as targeting sequences for autophagy and 
endocytosis, activates kinases or play a role in activation of DNA-repairing enzymes 
[47-49]. On the other hand, K48-polyubiquitin chains function as targets for 
proteasomal degradation [50]. 
1.3.2. The ubiquitination process 
The mechanism of protein ubiquitination comprises 3 different groups of enzymes, 
which are the ubiquitin-activating enzymes (E1), the ubiquitin conjugating enzymes 
(E2) and the ubiquitin ligases (E3). The ubiquitination mechanism starts with the ATP-
dependent activation of one ubiquitin molecule. This reaction is catalyzed by one of 
eight E1 enzymes, maintaining the bond between the C-terminal glycine of ubiquitin 
with a cysteine residue of E1. In a second step ubiquitin is transferred to cysteine 
residue of an E2 enzyme. In a last step, one of the several E3-ubiquitin ligases, the 
substrate and the E2 enzyme with the bound ubiquitin molecule build a complex, where 
ubiquitin is transferred to the substrate. Ubiquitin tagging of the substrate can be 
conducted by two possible reaction pathways. Either ubiquitin is transferred directly to 
the substrate or in a two step mechanism. It depends on the participating E3 ubiquitin 
ligase that transfers ubiquitin to the proteins. E3 enzymes with an RING-motif transfer 
ubiquitin directly to the substrate. whereas E3 enzymes with a HECT-motif bind the 
ubiquitin molecule first on themselves and afterwards to the substrate [51,52] (Fig.1). 
 
1.4. The Heat Shock Protein family 
Any protein that has the ability to stabilize and/or support another protein to obtain its 
functional conformation can be defined as a chaperone molecule [53]. Most of the 
known chaperones belong to the family of heat shock proteins (Hsps). Although Hsps 
are also constitutively expressed in mammalian cells, they are highly inducible by a 
diversity of proteotoxic stress stimuli, such as heat stress or oxidative stress [54,55]. 
The Hsp family can be subdivided into two groups of chaperones: first, the molecular 
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chaperones, including Hsp100, Hsp90, Hsp70, Hsp60/chaperonins and Hsp40 and 
second, the small Hsps (sHsps), comprising for example heme oxygenase-1 (Hsp 32) 
and Hsp27 [56]. Even though all of these Hsps have different protein sizes and 
functions, they are united by the similarity to have one or more heat shock elements 
(HSEs) in their promotor region, functioning as binding sides for the activating heat 
shock factors (HSFs) [57]. 
Molecular chaperones are responsible for protein (re)folding, stabilization of proteins 
within the cytosolic compartment and support of the ubiquitination process. In contrast 
to sHsps, enzymatic activity of molecular chaperones is highly ATP-dependent and co-
regulated by several co-chaperones [58]. On the contrary, sHsps are ATP independent 
and do not interact with co-chaperones, but rather form large homo-oligomers to 
mediate their chaperone-function. Binding of this large sHsp-oligomers to proteins in a 
non-native state prevents substrate aggregation and creates a reservoir of unfolded 
proteins for subsequent refolding by interacting molecular chaperones [59].  
1.4.1 Hsp90 
Under normal physiological and constitutive conditions Hsp90 is already present at very 
high concentrations in the cytosol and can be further up-regulated in stress situations. 
High basal levels of Hsp90 allow augmented binding occurrence and short-lived 
interactions with client proteins. The Hsp90 chaperone is a flexible dimer, whereas 
every monomer consists of a N-terminal domain which is connected via a long linker 
sequence with a M-domain and ends up with a C-terminal domain [60]. The C-terminal 
domain is necessary for Hsp90 dimerization. The M-domain is responsible for substrate 
binding and interaction with the co-chaperone AHA-1 during one folding cycle. The 
ATP-bind site is located at the N-terminus of Hsp90 [61,62]. Binding of ATP results in 
a dimerization of the N-terminal domains and forms a “molecular clamp”, which is 
needed for substrate processing. Hydrolysis of ATP, which is the rate limiting step of 
the cycle, resolves the molecular clamp and leaves the Hsp90 dimer in an open 
conformation. Hydrolysis of ATP and therefore the efficiency of the Hsp90 processing 
cycle is influenced by some co-chaperones. AHA-1 stimulates ATP hydrolysis, whereas 
CDC37 and HOP inhibit the N-terminal ATP hydrolysis activity and block the 
dimerization of the N-terminal domains. In addition, p23 stabilizes the dimerized form 
of Hsp90 before ATP-hydrolysis [63,64]. Beyond protein (re)folding, Hsp90 is 
responsible for binding and stabilization of a special, defined group of proteins, called 
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clients. The wide field of client proteins comprises protein kinases, nuclear hormone 
receptors, cell surface receptors or transcription factors in the cytosol [65]. Therefore, 
Hsp90 plays also a role in RNA transcription, RNA processing, DNA replication, DNA 
recombination, DNA repair and DNA metabolism [66]. 
1.4.2 Hsp70  
Due to its multiple functions, Hsp70 is the best examined heat shock protein. Function 
of Hsp70 comprises folding and stabilization of newly synthesized proteins, membrane 
translocations of secretory proteins, proofreading (in collaboration with Hsp40) and 
repair/refolding of damaged, unfolded or partly aggregated proteins [67-70]. To cope 
with all of these different obligations, the 70 kDa chaperone is expressed as a 
constitutive form (Hsc70; gene: HSPA8), maintaining the normal cell function, and as a 
stress inducible form (Hsp70/72; gene: HSPA1A, HSPA1B and HSPA1L), which is 
mainly responsible for the prevention of protein damage or protein aggregation as well 
as the re-establishment of functional proteins. 
Although, there are different forms of Hsp70, the general structure of the chaperone is 
equal. The N-terminal domain is responsible for ATP binding and hydrolysis, whereas 
the C-terminal domain, consisting of a β-sandwich domain and an α- helical domain, is 
responsible for substrate binding [71]. The β-sandwich detects protein segments, which 
are enriched in hydrophobic amino acids, especially when they are close to positive 
charged residues, indicating an unfolded protein [72]. Substrate affinity of the β- 
sandwich and the α-helices depends on the ATP-status of Hsp70, which is coordinated 
by some co-chaperones. The ATP bound form of Hsp70 shows a low affinity to the 
bound substrate and is therefore responsible for a rapid binding, processing and release 
of the substrate, while the ADP-bound form possesses a much higher affinity to the 
bound substrate and thus binding and release of proteins expires in a very slow way 
[73]. In the ADP-bound state, one of the α-helices of the substrate binding domain 
(SBD) forms salt bridges and hydrogen bonds to the outer loops and thereby closing the 
substrate binding pocket like a lid [74]. Closure of the lid can strongly be accelerated by 
interaction of Hsp70 with the co-chaperone Hsp40, functioning as an ATP-hydrolysis 
activator. Additionally, Hsp40 is also involved in the detection of unfolded proteins and 
the recruitment of Hsp70 to such substrates [75,76]. There are also two other co-factors, 
influencing ATP-hydrolysis of the N-terminal Hsp70 domain. HIP binds to the N-
terminal ATPase domain and stabilizes the ADP-bound state of Hsp70, promoting 
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therefore the folding activity the chaperone [77]. The opponent of HIP is Bag-1, which 
is a member of the Bag protein family. Bag-1 possesses like all members of the Bag 
protein family a Bag domain which is necessary for the interaction with the N-terminal 
ATPase domain of Hsp70. Bag-1 functions as an acceleration factor of ADP release at 
the N-terminal ATPase domain and facilitates the start of a new ATP cycle of the 
chaperone [78]. 
1.4.3 Interaction of Hsp90, Hsp70 and the co- chaperone CHIP 
As it was mentioned Hsp90 is responsible for the binding and stabilization of client 
substrates. Among these clients are kinases like Raf, enzymes like NOS, signaling 
proteins like VEGF, and growth factor receptors like GR or the polyglutamine androgen 
receptor [79,80]. Before these client proteins become substrates of Hsp90 stabilization, 
they have been partly folded by Hsp70. In a complex made of Hsp70 and Hsp90, which 
is linked by another co-chaperone called HOP, Hsp70 delivers the folded client to 
Hsp90. This process is connected to several conformational movements of the 
chaperones and is therefore ATP-dependent.  
Substrate proteins, which are despite of several folding cycles not foldable, become 
ubiquitinated by the co-chaperone CHIP. CHIP is a RING domain - E3 ubiquitin ligase 
with a TPR domain at its N-terminus, enabling the interaction with EEVD-domains of 
Hsp70 and Hsp90. On the C-terminus of CHIP there is a “U-box” domain that interacts 
with the UBCH5 family of E2 ubiquitin-conjugating enzymes [81]. Binding of CHIP to 
the TPR acceptor site of Hsp70 results on the one side in a retardation of the protein 
refolding process and on the other side in a transformation of the Hsp70 chaperone to a 
“chaperone- dependent ubiquitin ligase”[81]. To decelerate the ATP-cycle of Hsp70 and 
Hsp90, CHIP inhibits ATP hydrolysis, keeping the chaperones in a low substrate- 
affinity state. It is supposed that this “slowing down”-mechanism assists the loading of 
misfolded proteins from chaperones into the ubiquitin-proteasome machinery [81,82]. 
Due to its TPR domain, Hsp90 is also up to associate with CHIP [83]. Interaction of 
CHIP with Hsp90, results in a remodeling of the chaperone, slowing down of the 
ATPase cycle and thus to an inhibition of Hsp90 client proteins [81]. It seems that there 
are two possible scenarios for CHIP mediated ubiquitination and degradation of Hsp90 
clients. Some client proteins, such as GR, are ubiquitinated by CHIP during they are 
bound to Hsp90 [81]. Others, like ErbB2, are first transferred back to Hsp70 before they 
become ubiquitinated by CHIP[84].  
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Figure 2: Folding or degradation of chaperone substrates.  
Folding: The folding process of Hsp70 depends on ATP and several co-chaperones. After 
ATP and the substrate has bound to Hsp70, HIP binds to the N-terminal ATPase- domain 
and Hsp40 binds to the C-terminus, resulting in a fast hydrolysis of ATP to ADP and a 
stronger affinity to ADP by the chaperone. At this constitution Hsp70 has a strong binding 
affinity to the substrate, allowing proper folding of the protein. If interaction with Hsp90 is 
necessary HOP replace Hsp40 and functions as a linker molecule between Hsp70 and 
Hsp90. Degradation: In the state, when Hsp40 and HIP has bound to Hsp70 BAG-1 
replace HIP at the ATPase-binding domain. Following the dissociation of Hsp40 and HIP, 
ADP is exchanged by new ATP and the TPR containing-protein CHIP binds to the C-
terminal EEVD domain. CHIP inhibits the hydrolysis of ATP and ubiquitinates the bound 
substrate, as well as Hsp70 and BAG-1. K-11 linked ubiquitination of Hsp70 and BAG-1 
functions as a binding signal to the 26S proteasome, where the ubiquitinated substrate 
becomes degraded ([81,85,86] modified). 
 
1.4.4 Hsp32/heme oxygenase 1 and the Nrf-2 activation mechanism 
As it is indicated in the protein`s name, the substrate of heme oxygenase-1 (HO-1) is 
heme. HO-1 catalyzes the degradation of free heme into three components: Fe
2+
, 
biliverdin/bilirubin and CO [87]. HO-1 alias Hsp32 is as such not a typical heat shock 
protein. Although, HO-1 lacking conventional heat shock protein functions, such as 
protein stabilization or refolding of denatured proteins, it belongs to the heat shock 
protein family. This is due to the high stress activation of HO-1 and the occurrence of 
some HSE sequences in its promotor region [88-90]. Interestingly, HO-1 is inducible by 
several stress stimuli, comprising UV-irradiation, heavy metals or oxidative stress, but 
not by heat stress [91-93]. Besides HSF-1, the hmox1 gene activation is also regulated 
by AP-1, NF-κB and in particular by Nrf-2. 
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Nrf-2 is a universal transcription factor (TF), which is activated during a multitude of 
cellular stress stimuli, like xenobiotics and oxidative stress. Therefore Nrf-2 regulates 
the gene expression of genes, involved in oxidative stress resistance and xenobiotics 
detoxification [94]. All of these target genes possess one or more stress response 
elements (StREs) (also called antioxidant or electrophile response element 
(ARE/EpRE)), which are the binding receptor of Nrf-2 in the up-stream-located 
enhancer regions of target genes. Usually Nrf-2 heterodimerizes with small Maf 
proteins in the nucleus to function as ligands for StREs [95]. The regulatory domains of 
hmox1 can be subdivided into three parts, whereas two of them are highly assembled 
with StREs [96].  
In unstressed cells Nrf-2 is captured in the cytosol by its inhibitor Keap-1 (Fig. 3). 
Keap-1 binding site of Nrf-2 is the highly conserved region Neh2. Nrf-2 and Keap-1 
function as a sensitive sensor of oxidizing electrophiles and other stress stimuli. In the 
cellular resting state, reactive cysteins (C273 and C288) of the Neh2 binding site of 
Keap-1 are in a reduced state, keeping the bound to Nrf-2 stable and sequester the TF in 
the cytosol. Exposure to oxidative stress leads to an oxidation of the C273 and C288 
and the liberation of Nrf-2 [97]. Due to the Keap-1 supported ubiquitination of Nrf-2 
and its degradation by the proteasome, the half-life of Keap-1 bound Nrf-2 is relatively 
short. During the ubiquitination process of Nrf-2, Keap-1 recruits the E3 ubiquitin ligase 
Cul-3/Rbx1 and functions as a substrate adaptor for Cul-3/Rbx1, resulting in the 
ubiquitination and degradation of Nrf-2 (Fig.3) [98].This is the reason for low basal 
levels of Nrf-2 in unstressed cells [99]. Treatment of cells with electrophiles 
significantly prolongs the half life of Nrf-2, increase the total amount of it and leads to a 
translocation into the nucleus of Nrf-2 [100]. Moreover, Nrf-2 activation is dependent 
on different signaling pathways, which are also responsible for Nrf-2 liberation and 
phosphorylation. Following signaling pathways/kinases are involved in Nrf-2 
activation: PI3K-, PKC-, ERK and the MAPK pathway (Fig. 3) [101,102]. Depending 
on the respective stimulus one of these three pathways or kinases phosphorylates a 
serine residue in the Neh2 region of Nrf-2, supporting the disruption of Keap-1 and Nrf-
2 [103]. 
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Figure 3: Nrf-2 Signaling Pathway. 
In unstressed cells Nrf-2 is sequestered in the cytosol by Keap-1, leading 
to a Cul-3/Rbx1 dependent degradation of Nrf-2 by the proteasome. 
Under stress conditions Nrf-2 dissociates from Keap-1 and becomes 
phosphorylated by kinase activity. Phosphorylated Nrf-2 translocates into 
the nucleus and binds together with small Maf to several StREs, inducing 
gene transcription of several stress response proteins ([104] modified). 
 
1.5 Histone deacetylase 6 (HDAC6)  
Classical HDACs can be subdivided into two major classes. Class I HDACs include 
HDAC 1, 2, 3, 8 and class II HDACs comprise HDAC 4, 5, 6, 7, 9, 10. HDAC11, a 
recently found HDAC, is closely related to HDAC1, however, due to a too low overall 
sequence similarity, HDAC11 could not be allocated to class I or II HDACs [105]. Most 
HDACs contain a NLS, but can also be located in the cytosol as well. The four members 
of class I HDACs are primary located in the nucleus, whereas class II HDACs are able 
to switch between the nucleus and the cytosol. Especially HDAC6 is predominantly 
located in the cytoplasm [106]. The general function of HDACs is the removal of acetyl 
groups from histones comprising the nucleosome. Hypoacetylation results in a tighter 
wrapping of the DNA around nucleosomes and decrease the accessibility for 
transcription factors (TFs), which is tantamount with a transcriptional repression. Thus, 
HDACs play a crucial role in signal transduction, regulation in gene expression, cell 
growth and cell death [107]. 
Within the family of HDACs, HDAC6 is a rather unique enzyme. The identity of 
HDAC6 with other human HDACs is very low. With regard to the structure of HDAC6 
it is remarkable, that the protein contains two catalytical deacetylation domains instead 
of one. Moreover, HDAC6 possesses in contrast to the other HDACs a C-terminal 
ubiquitin binding domain, enabling the deacetylase to recognize and bind ubiquitinated 
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proteins [108]. Due to cytosolic location of HDAC6, HDAC6 target proteins are mainly 
cytosolic proteins. Prominent substrates are tubulin [109], Hsp90 [110], Ku70 [111] and 
cortactin [112]. Thus, HDAC6 plays a critical role in the regulation of cell motility, 
apoptosis, autophagy and maintenance of proteostasis [113-117].   
 
1.6 Oxidative stress and protein modifications 
There are several reasons why proteins become modified and therefore unfunctional. 
Inherited mutations, UV-irradiation, heat stress, heavy metal intoxications and oxidative 
stress are all possible stress stimuli, leading to protein modifications [118]. Especially 
oxidants have the ability to react with nearly all amino acids, forming protein 
modifications like protein carbonyls or oxidation of sulfur containing groups. 
1.6.1 Oxidative stress 
Per definition, oxidative stress is the imbalance between reactive oxygen species (ROS) 
formationand the antioxidative system, whereas there is an overbalance on the side of 
ROS [119]. ROS includes a large group of different oxygen-containing molecules, 
which are separated into free radicals, such as superoxide anion (˙O2
-
), hydroxyl – and 
lipid radicals (˙OH) as well as oxidizing non-radical species like hydrogen peroxide 
(H2O2), peroxynitrite (ONOO-) and singlet oxygen(
1
O2) [120]. The main source of ROS 
is the respiratory chain of the mitochondria, where ROS are continuously produced by 
one - electron reduction of molecular oxygen. Enzymes like NAD(P)H oxidases, 
xanthine oxidase, cyclooxygenase and lipoxygenase are also key sources for cellular 
generated ROS [121]. But ROS are not only a product of cellular enzymes, 
environmental factors like UV-irradiation or metal-ions such as Fe
2+
 (Fenton-reaction) 
are also possible reasons for the generation of ROS [118].  
Due to the continuous generation of ROS, cellular systems have a large arsenal of 
several antioxidants available to prevent oxidative damages. The antioxidative 
protection system can be divided into internal and external antioxidants. Cellular 
expressed enzymes like catalase, superoxide dismutase or the glutathione system count 
among the internal antioxidants. External antioxidants are antioxidative vitamins like 
ascorbic acid and tocopherols or secondary plant products like polyphenols [118]. Due 
to inherited alterations of antioxidants expression, adverse lifestyle conditions, 
malnutrition or the ageing process, the antioxidative protection declines, leading to an 
overbalance of ROS and oxidative stress [118]. The chronic exposure to oxidative stress 
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over years, is suggested to be a major reason for the ageing process [122] and many 
age-dependent diseases like Alzheimer’s Diseases [123], Parkinson’s Disease [124], 
Huntington’s Disease [125], heart failure [126], cataract and AMD formation [127,128], 
skin ageing [129], atherosclerosis [130], type 2 diabetes [130] and cancer [131].  
 
1.6.2 Oxidative protein modifications 
Besides lipids and the DNA, proteins are the most vulnerable targets of oxidation 
reactions. Oxidative modifications of proteins affect single amino acids, peptides or 
whole proteins with the ability to accumulate and forming aggregates. The consequence 
of protein oxidation is an impairment of receptor functionality, antibodies, signal 
transduction pathways, transport proteins and enzymes. Therefore, oxidative protein 
damage is a far reaching problem, because it affects also other biomolecules, for 
example by raising Ca
2+
 levels [132] or increasing DNA mutations by faulty DNA 
repair or synthesis due to oxidative modified DNA polymerases. 
Oxidative modifications of proteins can either occur by direct attack of ROS or by 
secondary reactions with end products of lipid peroxidation, such as MDA [133] or 
HNE, [134] or glycation products [135]. Very prone amino acid residues for oxidative 
modifications are the sulfur group-containing amino acids cysteine and methionine, 
amino acids containing an additional nitrogen group like arginine, lysine and proline, 
the amino acid glutamyl and the aromatic amino acids like phenylalanine or tyrosine, 
histidin, threonin [136]. Besides a multitude of special and unique single-amino acid 
modifications, as the generation of 2-Oxohistidine, 3-Nitrotyrosine or the production of 
methionine sulfoxide (MetO), the occurrence of protein carbonyls affects a larger group 
of amino acid residues. In particular, the oxidative reaction with arginine-, lysine, 
proline-, threonine- and glutamic acid results in the formation of protein carbonyls 
[137,138]. Due to the widespread distribution of protein carbonyls, they are common 
used marker for oxidative protein modifications. By derivatization of protein carbonyls 
with 2,4-dinitrophenylhydrazine, protein carbonyls can be detected using ELISA 
techniques, immunoblotting or immunochemistry [139]. Studies, which screened the 
subcellular distribution of protein carbonyls, found that protein carbonyls are co-
localized with ROS generating organelles, like the mitochondria [140,141]. In contrast 
to methionine sulfoxide or sulfur-nitrosylation, protein carbonyls are non- reversible 
protein modifications. Thus, suchlike proteins have to be degraded by the proteasome. 
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1.7 RNA interference (RNAi) techniques for proteins suppression  
Gene silencing by RNAi techniques is a modern and potent method to examining the 
function of distinct genes/proteins, the involvement of one protein in a complex 
pathway, drug target discovery/validation and therapeutics [142]. RNAi is a conserved 
and natural biological response, which can be found in nearly all eukaryotic organisms. 
In plants and some prokaryotes RNAi is an essential part in the defense mechanism 
against virus RNA [143]. In most multi-cellular organisms RNAi plays an important 
role in the regulation of gene-expression, especially for the coordination of the immune 
system [144]. Thus, any eukaryotic cell possesses a complete set of different enzymes, 
which are necessary for the processing of interfering RNAs. For gene silencing via 
RNAi there are two major possibilities, either by the application of short hairpin RNA 
(shRNA) or small interfering RNA (siRNA). siRNAs are short, double stranded RNA 
(dsRNA) sequences with the ability to interfere with coding mRNAs after a cellular 
processing procedure. After transfection the long dsRNA is processed in a first step by a 
dicer endonuclease into small, double stranded siRNA sequence with a length of about 
21 nucleotides. 19 nucleotides of this processed RNA form a helix, whereas each 3’end 
remains unpaired. In a second step the double stranded siRNA interacts with the RNA-
induced silencing complex (RISC).Within the RISC the double stranded siRNA 
becomes unwind by helicases, offering the sense strand of the siRNA for degradation. 
The loaded antisense strand of the siRNA and the RISC bound the target mRNA, 
resulting in a cleavage of the coding mRNA and a prevention of protein biosynthesis 
[144,145]. Commercially available siRNAs are already processed with bacterial 
recombinant Dicer and interacts after transfection directly with the RISC. 
The mechanism of shRNA processing is very similar to the process of conventional 
siRNA. shRNA is a sequence of RNA nucleotides, forming tight hairpin turns inside the 
sequence. After processing by dicer enzymes and interaction with the RISC, shRNA 
functions like normal siRNAs, leading to the degradation or blockade of the 
complementary target mRNA strand [144]. But, in contrast to “ordinary” siRNA, 
shRNA is part of a vector, which is then incorporated in the target genome. Transfection 
of shRNA vectors is commonly conducted via electroporation [146] or lentiviral 
transfer [147]. In general the used vectors are equipped with a U6 or H1 promotor for 
shRNA transcription. These promoters regulate the synthesis of small, highly abundant 
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non-coding RNA and have not any intragenetic control regions [148]. During 
transcription via polymerase III, a self complementary RNA is produced, forming the 
shRNA.  
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2. Aim of the work 
Maintenance of protein homeostasis is central for the functionality and survival of the 
cell. Impairment of protein homeostasis is closely connected to various diseases. 
Especially during the ageing process, when some of the protein homeostasis control 
mechanisms decline, disturbances in proteostasis lead to age dependent diseases as 
neurodegeneration, atherosclerosis, cataracts, skin ageing or diabetes. To preserve 
proteostasis there exist either the possibility to repair/refold damaged proteins or 
degrade misfolded proteins. The two major systems fulfilling this assignment are the 
ubiquitin-proteasomal system and the family of chaperones.  
The role of the ubiquitin-proteasomal system in proteostasis during oxidative stress and 
the mechanisms after proteasome malfunction in regard to maintain proteostasis were 
the major goals of this work. The data can give a better understanding about age-
dependent diseases or cancer therapies, using proteasome inhibitors.  
The following aspects of proteasomal function were investigated: 
 First a comprehensive overview on the current knowledge about the ubiquitin-
proteasomal system, during oxidative stress, disturbances of the protein 
homeostasis by oxidative stress and the connection to the ageing process and 
age-related diseases has to be given (Publication I). 
 In a next step it should be determined how the proteasome and ubiquitin are 
involved in the degradation of oxidized proteins after the exposure to different 
oxidizing stress stimuli (Publication II). 
 Further on it was required to establish a system to isolate ubiquitinated proteins 
and test for their oxidation status (Publication II and III) 
 In further experiments the identity of the polyubiquitinated proteins after 
oxidative stress of Publication II were determined and categorized (Publication 
III). 
 Additionally it should be elucidated, how these determined proteins are 
associated and what is the kinetic of their proteasome dependent degradation 
(Publication III) 
 Due to the central part of the proteasome in the maintenance of proteostasis, it is 
a major point of interest what happen with proteostasis and the proteostasis 
control system during proteasomal failure. Therefore, the response of 
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chaperones to proteasome inhibition was studied by determination of gene 
expression- and protein expression levels (Publication IV).  
 Since it was demonstrated for the first time that the non classical heat shock 
protein HO-1 (Hsp32) is also up regulated after proteasome inhibition, the 
molecular pathways involved in HO-1 induction upon proteasome inhibition has 
to be elucidated (Publication IV). 
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3. Publications 
 
3.1 Publication I: Protein Oxidative Modification in the Aging Organism 
and the Role of the Ubiquitin Proteasomal System 
Marc Kästle, Tilman Grune 
Current Pharmaceutical Design, 2011, 17(36):4007-22 
 
Oxidative stress plays a crucial role in the development of the ageing process and age-
dependent diseases. The majority of these diseases are closely connected to disturbances 
of proteostasis by protein oxidation and an impairment of the ubiquitin-proteasomal 
system (UPS). This review summarizes the function of the UPS, protein oxidation and 
the ageing process. It clearly shows how protein oxidation leads to an impairment of the 
UPS and to several connected age-dependent diseases.   
 
Own work: 
 Literature research 
 Writing of the manuscript 
 Preparation of figures 
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3.2 Publication II: Proteins bearing oxidation-induced carbonyl groups are 
not preferentially ubiquitinated 
Marc Kästle, Tilman Grune 
Biochimie, 2011, 93: 1076-1079 
 
There is an ongoing discussion about the proteasomal degradation of oxidative modified 
proteins. The majority of publications show a connection between oxidized proteins and 
an ATP and ubiquitin-independent degradation by the 20S proteasome. However, there 
are also evidences that there is an increase of ubiquitinated proteins upon oxidative 
stress. This work should add clarity on the proteasomal degradation of oxidized 
proteins. 
Thus, cells were treated with hydrogen peroxide and UV-A irradiation, causing cellular 
oxidative stress. Detection of carbonylated and ubiquitinated proteins by 
immunoblotting reveals that most oxidized proteins are not ubiquitinated. Isolation of 
ubiquitinated proteins by immunoprecipitation confirm that most protein carbonyls 
containing proteins are not ubiquitinated. The results of this study support the thesis that 
oxidized proteins are preferentially degraded by the 20S proteasome in an ubiquitin- 
independent manner and shows how the proteasome is involved in the cellular response 
to oxidative stress. 
 
Own work: 
 All practical experiments, including cell culture, western blots and 
immunoprecipitation 
 Writing of the manuscript, creating the figures and preparation of the statistical 
analysis 
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a b s t r a c t
A substantial part of soluble, oxidized proteins are degraded by the proteasome. However, it is still under
debate whether these oxidized proteins are degraded by the 26S proteasome in an ubiquitin-dependent
way or in an ubiquitin-independent way by the 20S proteasome. Therefore, we treated cells with H2O2
and UV-A irradiation and detected protein carbonyls and ubiquitination by immunoblotting. Separation
of ubiquitinated proteins from non-ubiquitinated reveals that most oxidized proteins are not
ubiquitinated.
 2011 Elsevier Masson SAS. All rights reserved.
1. Introduction
The bulk of soluble intracellular and nuclear proteins are
degraded by the proteasome. The proteasome consists of a cylin-
drical 20S core unit, which is capable to degrade proteins in an ATP-
independent way. The 26S proteasome, which degrades proteins in
an ATP-dependent way, consists of the 20S core unit and up to two
19S regulator units [1]. For recognition and degradation of proteins
by the 26S proteasome, it is necessary, that proteins are taggedwith
a polyubiquitin-chain. Ubiquitin is an intracellular peptide, which
has a multitude of functions among which is also the label of
proteins for degradation by the 26S proteasome. It seems to be
accepted, that most abnormal, damaged or oxidized proteins are
degraded by the proteasome, including 70e80% of oxidized
proteins [2]. However, which form of the proteasome is involved in
the degradation of oxidized proteins is still a matter of debate.
Whereas numerous groups accumulated convincing evidence for
the degradation of oxidized proteins in an ATP- and ubiquitin-
independent fashion [2e8], a limited number of experiments seem
to indicate some possible role of ATP or ubiquitin [9e12]. So the
group of Taylor could show in several publications, that there is an
increase of protein carbonyls and ubiquitination after exposure to
hydrogen peroxide [9,13]. Medicherla and Goldberg found some
evidence on a role of ubiquitination after oxidative stress in yeast
[12]. Since due to the undoubted role of proteasomal ubiquitin-
dependent degradation in stress response [14,15], and the array of
effects of oxidative stress on cell cycle and cell functionality, it is
highly expected that during oxidative stress an enhanced ubiq-
uitination occurs.
However, it still remains unsolvedwhether oxidatively damaged
proteins are preferentially/selectively ubiquitinated and degraded
by the 26S proteasome. By inducing oxidative stress with UV-A and
hydrogen peroxide and detecting oxidized and ubiquitinated
proteins by immunoblotting and separation of ubiquitinated and
non-ubiquitinated proteins we tried to resolve this issue.
2. Materials and methods
2.1. Materials
All chemicals were obtained from SigmaeAldrich (Deisenhofen,
Germany) or Carl Roth AG (Karlsruhe, Germany) unless otherwise
indicated. Chemicals for cell culture were provided from Biochrom
AG (Berlin, Germany).
2.2. Cell culture
All experiments were carried out, using the metastatic mela-
noma cell line WM451Lu. Cell cultivation was carried out like it is
described by Kästle et al. [16].
Abbreviations: ATP, adenosine triphosphat; H2O2, hydrogen peroxide; UV-A,
ultra violet A.
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2.3. Cell treatment
Cells were stressed with either hydrogen peroxide (H2O2) or
UV-A irradiation. H2O2 treatment was performed using 1 mM,
2 mM and 5 mM H2O2 in PBS for 0.5 h. Cell exposure to UV-A was
performed in a UV-A chamber (Dr. Gröbel UV-Elektronik GmbH,
Ettlingen, Germany) using 60 J/cm2. After cell exposure, PBS or
H2O2 solutions were exchanged to normal growth medium and
cells were incubated 16 h for recovery.
2.4. Cell isolation and immunoblotting
Cell isolation was conducted with standard protocol (lysis
buffer: 20 mM TRIS base, 100 mM sodium chloride, 5 mM EDTA).
Oxy-Blots were performed as described in Catalgol et al. [17]. After
membrane stripping, ubiquitinwas detected with an anti-ubiquitin
antibody (BML-KW0150, ENZO Life Sciences, Lörach, Germany)
(1:1000). The amounts were quantiﬁed by densitometry, consid-
ering background intensity, sample intensity and its area.
2.5. Capturing of ubiquitin-conjugated proteins
For isolation of ubiquitinated proteins, the UbiQapture-Q Kit,
containing a high-binding afﬁnity matrix based on immobilized
monoclonal anti-ubiquitin antibodies (UW8995-0001; ENZO Life
Sciences, Lörach, Germany) was used and the procedure was per-
formed as described in the manufacturer’s instructions. After the
separation there are three different fractions: the “Unbound Fraction”
(UF), which did not bind to the ubiquitin capture matrix, the “Elution
Fraction” (EF), which includes the proteins that were captured by the
ubiquitin capture matrix and are eluted in a secondary step and
a “Washing Fraction” (WF),which contains theproteinsof thewashing
steps. In most experiments the concentration of proteins in the
washing solution was below the detection limit.
3. Results
3.1. Protein oxidation and ubiquitination after H2O2 exposure
As a reliable marker for oxidized proteins in cells we measured
protein carbonyls after exposure to different concentrations of
H2O2. With an increasing H2O2-load of the cells there is a dose
dependent increase of protein carbonyls (Fig. 1A). For 5 mM H2O2
there is a high signiﬁcant augmentation (150%) of protein carbonyls
compared to the control. As expected ubiquitinated proteins also
increase after exposure to H2O2 (Fig. 1A, right blot). However,
comparing the molecular weight distribution of the signals for
oxidized and ubiquitinated proteins between the immunoblots, it
becomes obvious that there are many oxidized proteins, which are
not ubiquitinated (Fig.1A, H2O2). Oxidized proteins can be observed
Fig. 1. Protein carbonyls and ubiquitination after H2O2/UV-A treatment. Panel A shows one representative immunoblot out of three independent experiments. In panel B the
quantiﬁcation results of the three independent immunoblots of protein carbonyls and ubiquitinated proteins are presented. Panel C and D represent protein carbonyls and
ubiquitinated proteins at various time points after treatment and after lactacystin (20 mM) treatment. Shown are the Mean  SD; p < 0.05 ANOVA, *p < 0.05, **p < 0.01, statistical
signiﬁcance to control, Tukey post hoc test.
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in a molecular weight range from 250 kDa to 10 kDa. Especially the
regions from 100 to 50 kDa and 37 to 25 kDa contain a high amount
of protein carbonyls (Fig. 1A, H2O2). On the other hand a signal,
using an anti-ubiquitin antibody can only be detected in the high
molecular weight range. Therefore, it is clearly visible, that the
oxidative stress induced increase in signal intensity takes place in
the whole molecular weight range, whereas the ubiquitination
signal is increasing only in the high molecular weight range. Even
during kinetic studies and after lactacystin treatment it is obvious
that there are no changes in the molecular masses of carbonylated
and ubiquitinated proteins with time or upon blocking of the
degradation of ubiquitinated proteins (Fig. 1C and D).
3.2. Protein oxidation and ubiquitination after UV-A exposure
To test whether this phenomenon is also true for other oxidative
stress models, cells were exposed to UV-A. Exposure to 60 J/cm2 of
UV-A leads to a 1.7 fold signiﬁcant increase of protein carbonyls
(Fig. 1). Also the amount of ubiquitinated proteins after UV-A
irradiation is some 25% higher compared to the control. Addition-
ally there is the same protein distribution of carbonylated and
ubiquitinated proteins, as in the case of hydrogen peroxide treat-
ment (Fig. 1A). Therefore, it can be concluded that this is not
a special effect of H2O2 treatment, but rather a common effect after
cellular oxidative stress. However, it seems treatment with UV-A
irradiation produces lower amounts of ubiquitinated protein than
treatment with H2O2.
3.3. Detection of protein carbonyls and ubiquitinated proteins
after ubiquitin-capturing
Further on we separated the ubiquitinated proteins from the
non-ubiquitinated by using an ubiquitin capture matrix. Fig. 2A
shows the detection of protein carbonyls and ubiquitinated
proteins of the two protein fractions gained by this method. The
Unbound Fraction (UF), which contains the proteins, which were
not captured by the ubiquitin capture matrix, contains most of the
oxidized proteins after exposure to 5 mM H2O2 (Fig. 2). In
the Elution Fraction (EF), which contains the proteins captured by
the ubiquitin capture matrix e that means the ubiquitinated
proteins, only some 40e60% of the protein carbonyl concentration
of the unbound control could be detected. This indicates a clear
negative selection by the ubiquitin capture matrix for oxidized
proteins. The increase of protein carbonyls in the UF after exposure
to 5mMH2O2 is with 150% signiﬁcant compared to control proteins
of the UF and also signiﬁcant compared to the proteins of the EF
(Fig. 2).
Furthermore, the ubiquitin blots indicate that there is a signiﬁ-
cant increase of ubiquitination after 5 mM H2O2, as it was observed
in the experiments before (Fig. 2). Ubiquitinated proteins are found
predominantly in the EF fraction, which contains almost none of
the oxidized proteins. Consequently separation of ubiquitinated
and non-ubiquitinated conﬁrms the ﬁndings, that most oxidized
proteins are not preferentially ubiquitinated.
4. Discussion
In the current study, we could demonstrate that there is an
augmentation of oxidized proteins and ubiquitinated proteins after
exposure to several sources of oxidative stress. Furthermore, we
could show that most of the formed oxidized proteins are not
ubiquitinated. The bulk of oxidized proteins become degraded by
the proteasome [2]. Recognition and degradation of proteins by the
20S and the 26S proteasomes are different. In most cases substrates
of the 26S proteasome have to be ubiquitinated for degradation [5].
Pickart et al. have shown that it is mainly the hydrophobic effect of
Fig. 2. Protein carbonyls and ubiquitination after H2O2 treatment and separation of ubiquitinated proteins using the ubiquitin capture matrix. Cells were treated and lysed as
described above. Afterwards cells lysates were separated into the unbound fraction (UF, non-ubiquitinated proteins) and the bound and eluted fraction (EF, ubiquitinated proteins).
Fractions were analyzed as described above. Three independent experiments were performed. In panel A one set of representative blots is demonstrated, whereas in panel B the
quantiﬁcation of all three experiments is shown. Data are the means of three different experiments. Mean  SD; p < 0.05 ANOVA, *p < 0.05, **p < 0.01, ***p < 0.001, statistical
signiﬁcance to control and #p < 0.01, statistical signiﬁcant to both EFs, Tukey post hoc test.
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the polyubiquitin chain that allows recognition and degradation of
ubiquitinated proteins by the 26S proteasome [18]. In general the
26S proteasome is considered to be responsible for the degradation
of short lived, regulatory proteins and unfolded proteins. Therefore,
such proteins have to be tagged by a hydrophobic polyubiquitin
chain for degradation [5]. On the other hand multiple studies
demonstrated that oxidatively damaged proteins are good
substrates for the 20S proteasome, due to oxidant-mediated
unfolding and the increased surface hydrophobicity of the protein
substrate [4]. No ubiquitin is required for this degradation. There-
fore, moderately oxidized, unfolded and hydrophobic proteins
seem to be ideal substrates for the 20S proteasome, which works
ubiquitin independent [1,2]. Furthermore, it is likely, that oxidized
proteins are not suitable for ubiquitin binding, because oxidative
modiﬁcation of lysine residues to a-aminoadipic semialdehyde [19]
impairs proteins for ubiquitination. In addition to that, the group of
Davies has shown that ATP plays no crucial role in proteolysis
of oxidized proteins. Furthermore, it was observed that addition of
ATP decreases proteasomal degradation of oxidized proteins of
about 10e20% in cell free lysates [4,5,20].
The reported high level of ubiquitinated proteins after oxidative
stress as found by the group of Taylor in rabbit epithelial lens cells
shows the same molecular weight distribution as reported here
[10,11,13]. Since a separation of ubiquitinated and non-ubiquiti-
nated proteins was not performed in these studies we interpret the
results differently. Most likely a set of regulatory proteins is ubiq-
uitinated as a consequence of stress response. However, we could
show in the here presented data that a vast majority of carbony-
lated proteins is not ubiquitinated. These results ﬁt further in the
role of the 20S proteasome in the degradation of oxidized proteins
[2e8], the degradation of oxidized proteins in cells lacking an
ubiquitination system [5], and the loss of 26S proteasomal activity
during oxidative stress [21]. Reinheckel et al. have clearly demon-
strated that there is a loss of function of the 26S proteasome after
exposure to oxidative stress, whereas the 20S proteasome remains
unaffected [21]. Besides enhanced ubiquitination as a consequence
of the stress response, the loss of 26S proteasomal activity might
contribute to the accumulation of ubiquitinated proteins after
oxidative stress.
Additionally, in plants could be shown that a loss of 26S protea-
some activity leads to an increased 20S proteasome biogenesis, which
enhances the cellular capacity to degrade oxidized proteins [22].
In summary, it can be suggested that the majority of oxidized
proteins are not preferentially ubiquitinated and, therefore, not
degraded in an ubiquitin- and ATP-dependent fashion. Therefore, it
is likely that other proteolytic pathways, including the 20S pro-
teasome play a crucial role in the removal of oxidized proteins after
oxidative stress.
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3.3. Publication III: Chaperones, but not oxidized proteins, are 
ubiquitinated after oxidative stress 
Marc Kästle, Sandra Reeg, Adelina Rogowska-Wrzesinska, Tilman Grune 
Free Radicals in Biology and Medicine, 2012 submitted 
 
In publication II it was demonstrated that most oxidized proteins are not ubiquitinated, 
although there is also an increase of ubiquitinated proteins as part of oxidative stress. 
Due to this it is of special interest to identify the ubiquitinated proteins upon oxidative 
stress. 
Therefore, ubiquitinated proteins were treated with hydrogen peroxide (H2O2) and/or 
lactacystin (LC) and isolated by immunoprecipitation. The isolated fraction of 
ubiquitinated proteins was separated by gel-electrophoresis, visualized by Coomassie- 
staining and identified by MALDI-TOF-TOF analysis.  
As a result 24 proteins were identified and were dedicated to cytoskeleton/intermediate 
filament proteins, chaperones, energy metabolism proteins, transcription/translation 
regulators and clathrin. Just a few of them were uniquely identified when there was an 
involvement of H2O2. Only some chaperones presented increased ubiquitination. All in 
all the obtained results confirm that the majority of proteins found in the ubiquitin 
fraction upon oxidative stress are ubiquitinated due to regulatory reasons.  
 
Own work: 
 Tryptic protein digestion and preparation of the samples for MALDI-TOF-TOF 
analysis 
 Scientific instruction and design of western blot experiments 
 Literature research 
 Writing of the manuscript and making the figures 
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Abstract 
After oxidative stress proteins which are oxidatively modified are degraded by the 20S proteasome. 
However, several studies documented an enhanced ubiquitination of yet unknown proteins. Since 
ubiqutination is a prerequisite for degradation by the 26S proteasome in an ATP-dependent manner 
this raises the question whether these proteins are also oxidized and, if not, what proteins need to be 
ubiquitinated and degraded after oxidative conditions. 
By determination of oxidized- and ubiquitinated proteins we demonstrate here that most oxidized 
proteins are not preferentially ubiquitinated. However, we were able to confirm an increase of 
ubiquitinated proteins 16h upon oxidative stress. Therefore, we isolated ubiquitinated proteins from 
hydrogen peroxide treated cells, as well as from control and lactacystin, an irreversible proteasome 
inhibitor, treated cells, and identified some of these proteins by MALDI tandem mass spectrometry 
(MALDI MS/MS). As a result we obtained 24 different proteins which can be categorized into the 
following groups: chaperones, energy metabolism, cytoskeleton/intermediate filaments, and 
protein translation/ribosome biogenesis. The special set of identified, ubiquitinated proteins 
confirm the thesis that ubiquitination upon oxidative stress is no random process to degrade 
the mass of oxidized proteins, but concerns a special group of functional proteins. 
 
 
Keywords: Oxidative stress, ubiquitin, proteasome, proteolysis, protein oxidation 
  
Introduction 
Oxidative stress is defined as the imbalance between reactive oxygen species (ROS) and the 
antioxidative response mechanism, whereas under stress conditions an overweight of ROS 
exists [1]. Besides lipids [2] and the DNA [3], proteins are the most abundant targets for 
oxidative modifications upon oxidative stress. The most familiar protein-/amino acid 
modification upon oxidative stress is the formation of protein carbonyls. The most sensitive 
amino acids for oxidative –dependent carbonylation are arginine, lysine, proline, threonine 
and glutamic acid. Due to the high occurrence of protein carbonyls after oxidative stress, they 
are a well established biomarker for oxidative stress and the degree of oxidative protein 
damage [4,5]. In contrast with other oxidative protein modifications, like the formation of 
methionine sulfoxide (MetO), protein carbonylation is irreversible. Thus, proteins containing 
protein carbonyls have to be degraded by the proteasome, in order to maintain the cellular 
protein homeostasis [6].  
The proteasome is a cylindrically shaped, multicatalytical protease with a molecular mass of 
about 700 kDa [7]. The proteasome consist of a 20S core structure (also called the 20S 
proteasome), formed by two α-rings and two β-rings. The two β-rings possess the proteolytic 
activity of the proteasome, whereas the α-rings function as regulators of substrate access into 
the inner β rings. Additionally, the 20S proteasome is able to build complexes with different 
regulator subunits. If the 20S proteasome binds two 19S regulators –one on each side of the 
barrel- it forms the 26S proteasome [8]. The 26S proteasome binds and degrades, in an ATP-
dependent manner, polyubiquitinated proteins. Therefore, the great majority of the 26S 
proteasome substrates have to be polyubiquitinated by the E1- (ubiquitin-activating enzyme), 
E2- (ubiquitin-conjugating enzyme) and E3- (ubiquitin ligase) ubiquitination enzymes. Then 
several different subunits within the 19S regulator arrange the deubiquitination, unfolding and 
transfer of the substrate to the 20S proteasome [7]. In general the 26S proteasome is 
responsible for the degradation of the large spectrum of short lived regulatory-, onco- and 
structural proteins [8]. Degradation by the 20S proteasome alone is ATP- and ubiquitin- 
independent, however, the proteins have to be in an already unfolded state, exposing 
hydrophobic surface structures [9]. 
It was a matter of debate, whether oxidized proteins are degraded ubiquitin-independent by 
the 20S proteasome or ubiquitin-dependent by the 26S proteasome. A bulk of publications 
groups accumulated convincing evidence for an ubiquitin-independent degradation of most 
oxidized proteins by the 20S proteasome [10-16]. However, there are also some confusing 
results, indicating a possible role of the ATP/ ubiquitin-dependent degradation by the 26S 
proteasome [6,17,18]. So Shang et al. demonstrated, that there is a coincident increase of 
protein carbonyls and ubiquitinated proteins after exposure to hydrogen peroxide (H2O2) 
[17,18]. In a previous study, we could also observe an augmentation of protein carbonyls and 
ubiquitinated proteins after H2O2- or UV-treatment. However, we proposed that most oxidized 
proteins were not ubiquitinated by comparison of the molecular weight spectrum of oxidized 
proteins and the ubiquitinated ones [19]. This suggests that the majority of oxidized proteins 
are degraded in an ubiquitin-independent way and that ubiquitination upon oxidative stress 
affects only distinct proteins [19]. However, the question which proteins are ubiquitinated 
after oxidative stress remains unsolved. 
Therefore, we decided in the here presented study to confirm that oxidized proteins are not 
preferentially ubiquitinated and to elucidate the identity of ubiquitinated proteins after 
exposure to hydrogen peroxide. By separation and MALDI MS/MS analysis we identified 24 
ubiquitinated proteins after exposure to oxidative stress and tested their time dependent 
content in total and in an ubiquitin fraction. 
  
Materials and Methods 
 
Materials 
All chemicals are obtained from Sigma-Aldrich (Hamburg, Germany) or Carl Roth AG 
(Karlsruhe, Germany), unless otherwise indicated. Cell culture material were provided from 
Biochrom AG (Berlin, Germany) 
 
Cell Culture and oxidative stress 
For all experiments WM-451-Lu melanoma cells were used. Cells were cultivated in a 
humidified 37°C incubator with 5% CO2. Cell culture medium comprised MCDB 153 basal 
medium (with phenol red), 20% Leibovitz L15 medium, 2% fetal calf serum (FCS), 2 mM 
glutamine, 50 μg/ml gentamycin, and 5 μg/ml insulin. Medium was changed after 3 days. For 
hydrogen peroxide (H2O2) treatment cells were seeded on cell culture dishes (22 cm
2
). 
Reaching 80-90% confluence, cells were treated for 0.5h with 5 mM H2O2 solution, prepared 
in PBS. After the incubation, 5mM H2O2 was discarded and cells were cultured for additional 
16h in normal growth medium for recovery. In case of proteasome inhibition, normal growth 
medium comprised additional 20µM lactacystin (LC) for 16h.  
 
MTT viability assay 
To determine the cell viability after H2O2 and UV-A exposure the 3-(4,5-Dimethylthiazol-2-
yl)-2,5-diphenyltetrazoliumbromid (MTT) – viability assay (Carl Roth, Germany) was used. 
Following 16h recovery time, medium was exchanged by MTT solution (5 mg/ml). Following 
the incubation time of 1h, MTT-solution was discarded and cells were solubilized with 
DMSO containing 10 % SDS and 0.6 % acetic acid. Viability was determined on a 96 well 
plate reader at a wavelength of 580 nm (reference wavelength: 660 nm). 
 
Cell lysate preparation and isolation of ubiquitinated proteins 
For cell lysate preparation, cells were washed twice with PBS and treated with lysis buffer 
(20mM TRIS base, 100mM sodium chloride, 5mM EDTA). After homogenization and 
incubation on ice, cells were treated with ultrasound and subsequently centrifuged at 12500 
rpm for 10 min. The supernatant was used for further experiments. Protein content of the 
sample was determined by Bradford protein assay [20]. Cell lysates were either directly 
analyzed by immunoblot or the ubiquitinated proteins were isolated. For isolation of 
ubiquitinated proteins, the UbiQapture™-Q Kit, containing a high-binding affinity matrix 
based on immobilized monoclonal anti-ubiquitin antibodies was used and the procedure was 
performed as described in the manufacturer’s instructions (UW8995-0001; ENZO Life 
Sciences, Lörach, Germany). After the separation there are two different fractions: the 
―Unbound Fraction‖ (UF), containing ubiquitinated and non ubiquitinated proteins, the 
―Elution Fraction‖ (EF), which includes the proteins that were captured by the ubiquitin-
capture matrix (solely ubiquitinated proteins) and are eluted in a secondary step. Elution of 
ubiquitinated proteins was conducted with the ubiquitin hydrolase USP2 (BML-UW9850; 
ENZO Life Sciences, Lörach, Germany). Elution with USP2 results in a deubiquitination of 
the isolated ubiquitinated proteins. 
 
Gel electrophoresis and Immunoblotting 
30-50 µg protein of each sample was separated by SDS-page (gel: 7.5% acrylamide) and 
transferred onto nitrocellulose membrane. Derivatization and detection of protein carbonyls 
was conducted as described before in Catalgol et al. [21]. For detection of all other proteins 
the following antibodies were used: ms anti ubiquitin (BML-KW0150, ENZO Life Sciences, 
Lörach, Germany), ms anti Hsp70 (ab6535), ms anti Hsp90 (ab13492), rb anti β-tubulin 
(ab6046) (abcam, Cambridge, UK), ms anti β-actin (A5441, Sigma-Aldrich, Germany). 
Detection of the membranes was conducted with the Odyssey infrared detection system from 
LI-COR (LI-COR Biosciences, Bad Homburg). Blot evaluation was conducted with Odyssey 
Application Software Version 3.0 from Li-Cor. 
 
Coomassie staining, in-gel digestion, mass spectrometry protein identification and database 
searches 
Cell lysates for mass spectrometry were pooled and concentrated by Amicon Ultra centrifugal 
filters for protein purification and concentration (Milipore, Germany). Samples were 
separated by gel electrophoresis and stained with Coomassie for 0.5h. Following several 
washing steps with 10% acetic acid, all visible protein bands were excised and used for mass 
spectrometry protein identification. Sample preparation methods for mass spectrometry were 
modified from Shevchenko et al. [22]. Gel bands were washed with deionized water followed 
by two washes with 100% acetonitrile for 15min and 2 min respectivelly. Subsequently, the 
proteins in the gel plugs were reduced with 10 mM DTT for 0.5h and alkylated with 55 mM 
iodoacetamide for additional 0.5h. Following a washing step with 50% acetonitrile, samples 
were treated with 100% acetonitrile for 15min and the gel plugs were dehydrated in a vaccum 
centrifuge. In gel protein digestion was carried out using 2% trypsin (Promega Inc., Madison 
WI, USA) in 50 mM NH4HCO3 at 4°C. After 20 min trypsin incubation, the excess trypsin 
solution was exchanged by 50µM NH4HCO3 and digestion proceeded at 37°C overnight, 
followed by storage at -20°C until use. Peptide purification and concentrating was handled 
using in house prepared reverse-phase microcolumns as described before Ahmed et al. [23]. 
Bound peptides were eluted with 0.8 μL of matrix solution (5 μg/μL a-cyano-4-
hydrocynnamic acid in 70% acetonitrile and 0.1% TFA) directly onto the matrix assisted laser 
desorption ionization (MALDI) target plate. Peptide mass spectra were acquired in positive 
reflector mode on a 4800 Plus MALDI-TOF/TOF™ Analyzer (Applied Biosystems, Foster 
City, CA, USA). Each spectrum was generated with a total of 1000 laser shots and was 
externally calibrated using standard peptides from tryptic digested β-lactoglobulin. From the 
raw data output, peak lists were generated using Data Explorer (Applied Biosystems, Foster 
City, CA, USA). MS and MS⁄MS peak lists were combined into search files and used to 
search NCBInr protein databases using Mascot program (Mascot server version 2.3.0, 
Matrix Science, UK). The following search parameters were used: Database — NCBInr 
(October 2011), Taxonomy — Metazoa (Animals), maximum number of missed cleavages 1, 
cysteine carbamidomethylation as fixed and methionine oxidation as variable 
modification,mass tolerance of 70 ppm in MS mode and 0.6 Da for MSMS.  
Results 
Protein oxidation and ubiquitination upon exposure to H2O2  
To confirm the results from our preliminary study [19] and to clarify the distribution of 
protein carbonyls and ubiquitinated proteins, we treated cells with H2O2 and/or LC and tested 
the samples for protein carbonylation and ubiquitination. In Fig.1A it is indicated that there is 
an augmentation of protein carbonyls with increased stress stimuli. Treatment with LC alone 
shows only a slight or no increase of protein carbonyls compared with the control, indicating 
that LC mediates no severe oxidative stress. Exposure to H2O2 leads to a visible elevation of 
protein carbonyls compared to the control. By inhibiting the proteasome and additional 
treatment of the cells with H2O2 we detected an accumulated mass of protein carbonyls, 
observing the greatest amount of oxidized proteins compared to the other conditions (Fig. 
1A). With regard to ubiquitination, the treatment with LC results in an expected raise of 
ubiquitinated proteins. Treatment with H2O2 leads also to a further increase of ubiquitination. 
By comparing the molecular weights of oxidized and ubiquitinated proteins it can be observed 
that a majority of oxidized proteins are at a mass range between 15 kDa to 50 kDa, whereas 
the majority of ubiquitinated proteins are located above 70 kDa (Fig. 1A). To confirm that we 
investigate viable cells after the various treatments, we determined viability by an MTT assay. 
Cell treatment with LC, H2O2 or both reduces cell viability not more than 35% compared to 
the control (data not shown). 
Moreover, we decided to test whether there is the same time dependency of protein oxidation 
and ubiquitination. As it is shown in Fig.1B, protein carbonylation increases expectably very 
fast after H2O2 exposure, resulting in the highest concentration 1 h after start of the treatment 
(Fig. 1B). Contrarily the increase of ubiquitinated proteins is more moderate after H2O2 
treatment. Although, there is a slight increase directly after hydrogen peroxide treatment 
(0.5h) the long term accumulation of ubiquitinated proteins is much more dramatic. Again, 
throughout all time points the majority of ubiquitinated proteins are located in the high mass 
protein fraction (Fig. 1B). Since our original aim was to identify some of the preferentially 
ubiquitinated proteins after oxidative stress we choose the 16h incubation time after H2O2 
treatment for analysis. 
  
Isolation and determination of ubiquitinated proteins 
Thus we isolated the ubiquitinated proteins using the UbiQapture™-Q Kit (a method, based 
on immunoprecipitation) after exposure to H2O2 and/or LC and separated the proteins by gel 
electrophoresis. 24 different protein bands were analyzed by MALDI MS/MS (Fig. 2). All of 
the 24 bands were successfully identified. In Table 1 the protein names, accession number, 
Mascot score, theoretical protein mass (Da), sequence coverage (%), number of peptide 
matched and sequenced peptides are listed (Tab. 1). Among the isolated ubiquitinated 
proteins we found a large group of cytosolic proteins as well as proteins from cell organelles, 
such as mitochondria and the endoplasmatic reticulum. The identified ubiquitinated proteins 
can be categorized into the following groups: (i) chaperones, (ii) energy metabolism enzymes, 
(iii) cytoskeleton/ intermediate filaments, (iv) proteins participating in protein translation/ 
ribosome biogenesis/mRNA stabilization and (v) the clathrin heavy chain protein 1 (Fig. 3A). 
We identified eight proteins ubiquitinated in the control and after oxidative stress. This are the 
three chaperones Hsp90, Hsp70 and Hsp60 as well as the cytoskeleton and intermediate 
filament proteins β-tubulin, actin, vimentin and myosin, as well as the elongation factor 
eEF1a (Table 1, Fig. 3A).  
Additionally, we found also peptides belonging to ubiquitin, respectively ubiquitin C splicing 
variant which are indicated in Table 1 by the number 19 and 20. This is a further proof for the 
ubiquitination of the isolated proteins and the efficiency of separation of ubiquitinated 
proteins. The theoretical mass of this two ubiquitin samples are about 8.5 kDa and 17.0 kDa 
(Tab. 1). Interestingly the detected bands were cut out at a protein size of about 250 kDa, 
indicating the formation of polyubiquitin-chains with higher masses. We detected no 
additional proteins after LC treatment, so we proceeded only with control- and H2O2 treated 
cells for the next experiments. 
 
Comparison of ubiquitinated proteins between the control and H2O2 treated cells 
If some proteins are ubiquitinated in control cells and also after the treatment with H2O2 it is 
of special interest whether under stress conditions the amount of the given protein 
ubiquitinated is changing in comparison to control levels. Thus, we determined the blot 
density of the scanned coomassie gels (control and H2O2 treated) with the Odyssey 
Application Software and built the ratios of all these proteins between the control and H2O2 
treated cells. The value of the ratio reflects the relative difference between the two groups; a 
ratio of one indicates no change in protein levels between the two groups, whereas a ratio of 
two stands for the two fold increase in the amount of ubiquitinated proteins after H2O2 
treatment. Interestingly, after examining these eight mentioned proteins we found three 
proteins whose protein content increases in the ubiquitin fraction after oxidative stress: 
Hsp90, Hsp70 and Hsp60. Whereas after H2O2 treatment the content of ubiquitinated Hsp90 
doubled to a ratio of two, the Hsp70 and Hsp60 reached a 1.5 fold increase of ubiquitination 
compared to the control (Fig. 3B). In contrast, there is no remarkable difference between the 
control and H2O2 treated cells of the other 5 proteins. Ubiquitination of all the cytoskeleton 
and intermediate filament proteins seems to remain largely unchanged after oxidative stress. 
Surprisingly, the content of eEF1a in the ubiquitin fraction is even a little bit lower after H2O2 
than in the control (ratio: 0.9).  
As it was already shown in Fig.1A, that there is an increase of ubiquitination after H2O2 
treatment compared to the control. The total summarized band intensity of ubiquitinated 
proteins after H2O2 treatment was twice as high compared to the control (data not shown), 
confirming the results from Fig.1. We decided, therefore, to test whether the absolute amount 
and the share of chaperones, as the proteins preferentially ubiquitinated after oxidative stress 
is really increasing within the pool of total ubiquitinated proteins. As demonstrated in Fig.4 
the absolute level of ubiquitinated chaperones is more than twice as high compared to the 
control (Fig.4A) and the proportion of chaperones is increasing by almost one third, whereas 
the share of cytoskeletal proteins as the major ubiquitinated protein fraction under control 
conditions is rather declining. Proteins related to translation/RNA interaction do not change 
their share and a collection of further proteins is ubiquitinated, too. This underlines the 
preferential ubiquitination of chaperones after hydrogen treatment. 
 
Time dependent ubiquitination of identified proteins 
In a next step it would be interesting on the one hand to verify the densitometric results of the 
coomassie gels of the ubiquitination fraction and on the other hand examining the expression 
of these proteins in total cell lysates and the ubiquitin fraction. Hence, we performed an 
immunoblot of the interesting chaperones HSP70 and HSP90 and for comparison of the 
cytoskeleton protein actin. Here, we either took the whole cell lysate for immunoblotting or 
isolated first the ubiquitinated proteins and used the ubiquitin fraction for immunoblotting. In 
Fig.5 the immunoblots of whole cell lysates and the isolated ubiquitin fraction of Hsp70, 
Hsp90 and actin are shown at the indicated molecular weights of each of the proteins. In total 
cell lysate the content of functional HSP90, HSP70 and actin remained unchanged (Fig. 5). 
However, the ubiquitination of HSP70 and HSP90 was drastically increases (more than 50%), 
as indicated by the content of the protein in the ubiquitinated fraction. Interestingly, also the 
content of actin was somewhat higher (20 %) in the ubiquitinated fraction of hydrogen 
peroxide treated cells. This confirms the prominent detection of actin as a ubiquitinated 
protein by the mass spectroscopic determination. On the other hand the pure quantification by 
analyzing the coomassie gel band seems to be less sensitive to such minimal changes.  
Discussion 
In the current study we detected protein carbonyls and ubiquitinated proteins after oxidative 
stress. We were able to confirm results from a preliminary study of our group, where it was 
demonstrated that oxidized proteins are not preferentially ubiquitinated [19]. Due to the fact 
that there is also an augmentation of ubiquitinated proteins during oxidative stress, we 
isolated the ubiquitinated proteins, subjected them to MALDI MS/MS analysis and identified 
24 different proteins among the ubiquitin fractions.  
There is a wealth of literature demonstrating that that oxidized proteins are preferentially 
degraded by the 20S proteasome in an ubiquitin and ATP-independent manner [10-16]. In 
addition to that there is increasing evidence showing an instability and inhibition of the 26S 
proteasome during oxidative stress. It was suggested that under oxidizing conditions a 
disassembly of 26S proteasomes takes place, enhancing the 20S proteasome content, giving 
the possibility for a more effective removal of damaged, irreparable proteins [10,24-26]. In a 
recent published work of the group of Huang it is demonstrated the disassembly of the 26S 
proteasome into the two 19S regulators and the 20S proteasome by mass spectrometry upon 
treatment with H2O2 [26]. Further on, the loss of the 26S proteasome activity was 
accompanied by an accumulation of ubiquitinated proteins. However, although there was an 
accumulation of ubiquitinated proteins, it was additionally demonstrated that oxidized 
proteins were degraded by the remaining 20S proteasome. The H2O2 triggered disassembly of 
the 26S proteasome seems to be dependent on the proteasome interacting protein Ecm29. It 
was shown that Ecm29 is substantially recruited to the 19S regulator in response to oxidative 
stress, resulting in its dissociation from the 20S core particle [26]. Our group was already 
earlier able to show a decline of the 26S proteasome activity and content after oxidative stress 
[27,28] and later an involvement of HSP70 in the 26S proteasome dissociation [24]. By using 
temperature-sensitive ubiquitination deficient cells we could demonstrate, that cells under 
restrictive conditions – no ubiquitination possible – were still able to degrade oxidized 
proteins [29]. 
Although, it seems to be a clear fact, that ubiquitination is not a required prerequisite for the 
degradation of oxidized proteins, it is also documented by several groups that after oxidative 
stress an enhanced ubiquitination takes place [17-19,30]. However, it already by a pure 
comparison of the molecular weight distribution of the oxidized/carbonylated proteins and the 
ubiquitinated proteins it is obvious that this is a different protein pool. So it was demonstrated 
by us, that not the oxidized proteins were preferentially ubiquitinated after oxidative stress 
[19]. This again raises the question on the nature of the proteins ubiquitinated after oxidative 
stress. Here we identified overall 24 different ubiquitinated proteins, which can be allocated to 
several groups: chaperones, energy metabolism, cytoskeleton/intermediate filaments, protein 
translation/ribosome biogenesis and a clathrin protein (Fig. 3, Fig. 4). Compared with other 
studies conducting a proteomic approach to identify ubiquitinated proteins in untreated cells 
we find some similarities. Vasilescu et al. determined ubiquitinated proteins in human cancer 
cells (MCF-7) by mass spectrometry [31]. Similar to our results they also identified the 
chaperones Hsp60, Hsp70, Hsp90, the eEF1A and filaments like actin, β tubulin or filamin A 
in untreated cells. In a second study Vasilescu et al. could confirm the ubiquitination of Hsps 
and some cytoskeleton proteins like actin [32]. The results of Vasilescu et al. and our results 
are also in accordance with the findings of Matsumoto et al, which did a large scale proteome 
analysis of ubiquitinated proteins in HEK239T cells [33]. After protein categorization they 
also demonstrated the ubiquitination of Hsps, ribosomal and translation related proteins, 
proteins participating in the energy metabolism and proteins of the cytoskeleton [33]. In 
addition to these studies we also made a proteomic characterization of ubiquitination after 
oxidative stress. Upon the treatment with H2O2 we identified proteins of the untreated control 
and some new, additional proteins. Interestingly, some of the proteins that were already 
identified in the control increase in the ubiquitin fraction upon oxidative stress. Especially 
Hsps are more ubiquitinated after H2O2 treatment, whereas the cytoskeleton proteins remain 
largely unchanged. Whether all these ubiquitinated chaperones are destined for proteasomal 
degradation or whether some of them are ubiquitinated to change their functionality is not yet 
clear.  
In summary we could demonstrate for the first time that in response to oxidative stress HSP 
proteins are preferentially ubiquitinated, whereas the carbonylated/oxidized proteins are not. 
Interestingly, all of the identified ubiquitinated proteins are also ubiquitinated under control 
conditions, however to a lesser extent. Interestingly, the increase in the ubiquitination is not 
accompanied by changes of the functional protein level in the cell lysate and seems to be 
selective for some proteins.  The ubiquitination of chaperones is a late event after oxidative 
stress and takes place at a time point when most of the oxidized proteins are already removed, 
indicating that the chaperone activity of the proteins is not longer required. In conclusion this 
makes the enhanced ubiquitination after oxidative stress a regulatory phenomenon, reflecting 
the response of the cellular metabolism and not the removal of oxidized proteins. 
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Figure Legends 
 
Figure 1  Protein oxidation and ubiquitination in WM-451 melanoma cells 
Cells were treated and harvested as described in the Methods section. In panel A) one of three 
representative immunoblots of protein carbonyls (left part) and ubiquitinated proteins (right 
part) 16h after H2O2 and/or LC treatment is shown. Panel B) demonstrates the time 
dependency of protein carbonylation (left part) and ubiquitination (right part) after H2O2 
treatment. One of three representative immunoblots is show. 
 
Figure 2  Coomassie staining of ubiquitinated proteins  
Cells were treated and harvested as described in the Methods section Furhteron the fraction of 
ubiquitinated proteins was isolated using a UbiQapture™-Q Kit. After the isolation of 
ubiquitinated proteins two fractions were analyzed: unbound fraction (UF) and elution 
fraction (EF), resulting from the deubiquitination of the captured proteins. Electrophoresis 
was peroformed in an 7.5% acrylamide gel, followed by Coomassie staining. The black 
arrows indicate the excised proteins from the UF fraction of the Coomassie gels, which were 
selected for determination by MALDI MS/MS analysis. The results of the identification are 
listed under the indicated numbers in Table 1. 
 
Figure 3  Ubiquitination of proteins after oxidative stress 
A) Summary and categorization of the identified ubiquitinated proteins. The identified 
ubiquitinated proteins from Table 1 were categorized into 5 different functional groups (light 
gray boxes). In the dark gray boxes below, all proteins are listed which were found in the 
control and after H2O2 treatment. B) Comparison between the quantified Coomassie bands of 
the control and the H2O2 samples. A ratio of one means that there are no differences between 
the protein levels of the control and the H2O2 treated cells.  
 
Figure 4 Chaperones are preferentially ubiquitinated after H2O2 treatment 
This graph visualizes the absolute amoung (panel A) and the share (panel B) of the 
ubiquitinated proteins of a given protein group under control and oxidative conditions. The 
values were calculated by summarizing the band intensity of the grouped protein bands (panel 
A) and by dividing the level achieved in panel A by the sum of all identified protein band 
densities. This result is given in percent.  
 
 Figure 5  Expression of Hsp70, Hsp90 and actin in whole cell lysates and the  
 isolated ubiquitin fraction.  
Cell lysates were obtained like it described in ―Materials and Methods‖. Ubiquitin fraction 
was isolated using the UbiQapture™-Q Kit as described above. ―C‖ indicates the control, 
which was not incubated with H2O2 (black columns). The samples were treated H2O2, cells 
were harvested and protein analyzed according to the above described procedures 16h after 
hydrogen peroxide treatmentValues are the mean ± SD of 3 independent experiments. 
Table 1 
Ubiquitinated proteins in human WM451Lu melanoma cells upon oxidative stress and/or proteasome inhibition 
Sample Identification Accession no. Mascot 
score % 
Theoretical 
mass (Da) 
Sequence 
coverage 
% 
No. of 
matched 
peptides 
No. of 
matched 
MS/MS 
Treatment 
  
1 nucleophosmin isoform 2  gi 40353734 152 29617 23 5 3 H2O2 
2 Chain A, Ca2+-Binding Mimicry In The Crystal 
Structure Of The Eu3+- Bound Mutant Human 
Macrophage Capping Protein Cap G  
gi 21730367 329 38786   24 8 6 C, H2O2 , H2O2+LC, LC 
3 actin, cytoplasmic 1   gi 4501885 602 42052 44 13 6 C, H2O2 , H2O2+LC, LC 
4 Eukaryotic translation elongation factor 1 alpha 1   gi 48734966 484 50433 25 12 4 C, H2O2 , H2O2+LC, LC 
5 Tubulin, beta   gi 18088719 565 50096 43 14 7 C, H2O2 , H2O2+LC, LC 
6 Tubulin, alpha   gi 340021 858 50804 43  9  H2O2 , H2O2+LC 
7 vimentin  gi 62414289 972 53676 41 18 13 C, H2O2 , H2O2+LC, LC 
8 60 kDa heat shock protein, mitochondrial  gi 31542947 686 61187   32 14 8 C, H2O2 , H2O2+LC, LC 
9 cytoplasmic chaperonin hTRiC5 gi 609308 128 22059   28 4 2 H2O2+LC 
10 heat shock 70kDa protein 8 isoform 2 variant gi 62896815 631 53580 38 10 5 C, H2O2 , H2O2+LC, LC 
11 heat shock cognate 71 kDa protein isoform 1 gi 5729877 251 71082 22 7 5 H2O2+LC, LC 
12 78 kDa glucose-regulated protein precursor  gi 16507237 288 72402 17 12 6 H2O2 , H2O2+LC, LC 
13 heat shock protein HSP 90-alpha isoform 2   gi 154146191 782 85006   33 13 5 C, H2O2 , H2O2+LC, LC 
14 heat shock protein gp96 precursor  gi 15010550 213 90309   14 9 2 H2O2 
15 nucleolin, isoform CRA_c   gi 119591368 255 58576 15 5 3 H2O2 
16 hnRNP U protein   gi 32358 156 89631 13 7 2 H2O2 
17 CLTC protein  gi 30353925 179 189538 16 14 1 H2O2 
18 myosin-9 gi 12667788 329 227646 14 25 7 C, H2O2 
19 ubiquitin C splice variant gi 54300702 100 17142 38 3 3 H2O2+LC, LC 
20  ubiquitin  gi 229532 81 8446 25 3 1 H2O2+LC 
21 FASN variant protein  gi 68533031 261 279819 11 22 3 H2O2 
22 nonmuscle myosin heavy chain (NMHC)   gi 189036 129 145623 15 11 1 LC 
23 filamin A, alpha   gi 119593150 303 250859 13 16 7 H2O2 
24 fatty acid synthase gi 915392 79 275542 7 8 2 H2O2+LC 
 
Spots of interest were identified by MALDI-TOF/TOF-MS as described under Material and methods 
     
a
 Protein spot refers to numbered spots in Fig. 2 
     
b
 Mascot protein scores greater than 55 are significant (p<0,05) 
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3.4 Publication IV: Histone deacetylase 6 (HDAC6) plays a crucial role in 
p38MAPK-dependent induction of heme oxygenase-1 (HO-1) in response to 
proteasome inhibition 
Marc Kästle, Esther Woschee, Tilman Grune 
The Journal of Biological Chemistry, 2012, in revision 
The proteasome plays a crucial part in the network of protein homeostasis by degrading 
unfunctional, polyubiquitinated proteins. Inhibition of the proteasome results in an 
accumulation of polyubiquitinated proteins and urges the cellular system to deal with 
the increasing amount of polyubiquitinated proteins. In previous studies, it was 
described that there is an HDAC6-dependent up-regulation of some classical heat shock 
proteins, i.e. Hsp27and Hsp70, functioning as chaperones to prevent protein 
aggregation. It was also observed that there is an induction of heme-oxygenase 1 (HO-
1) alias Hsp32 upon proteasome inhibition.  
It could be verified in this study that there is an up regulation of classical heat shock 
proteins at gene and protein levels. As it was postulated, this up-regulation was 
dependent on the involvement of HDAC6. Moreover, it could be shown by HDAC6 
repression, using RNAi technology, that the induction of HO-1 upon proteasome 
inhibition is also HDAC6 dependent. Thereby, HDAC6 is involved in a signal pathway, 
mediated by p38MAPK activation and Nrf-2 translocation into the nucleus, where HO-1 
gene expression is started.   
The results of these experiments give new insights of the role of HDAC6 in proteostasis 
upon proteasome inhibition and help to understand the limited efficiency of proteasome 
inhibitor based cancer therapy. 
Own work:  
 Cell culture and cell treatment 
 siRNA transfection 
 Western blots and verification of gene expression by RT-qPCR 
 Separation of nucleus and cytoplasm 
 Immunocytochemistry, Immunoprecipitation 
 All enzymatic activity assays 
 Writing of the manuscript, preparing the figures and preparation of statistical 
analysis
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Background: Proteasome inhibition leads to an 
up-regulation of several heat shock proteins, 
including HO-1. 
Results: Deacetylation of p38 by HDAC6 
enables the induction of HO-1 upon proteasome 
inhibition.  
Conclusions: HDAC6 plays a crucial role in cell 
homeostasis upon proteasome inhibition. 
Significance: This work shows the mechanistic 
processes after proteasome inhibition, which is 
important for cancer therapy. 
 
Summary 
 The proteasome is responsible of the 
degradation of polyubiquitinated proteins. 
Inhibition of the proteasome leads to an 
accumulation of polyubiquitinated proteins 
and thus to an impairment of the cellular 
protein homeostasis. To prevent cellular 
damage upon proteasome inhibition there is 
an up-regulation of several heat shock 
proteins (Hsps), including Hsp27, Hsp70 and 
Heme Oxygenase-1 (HO-1). It was 
demonstrated that the induction of classical 
Hsps, such as Hsp27 and Hsp70, is dependent 
on a HDAC6-dependent mechanism which 
releases HSF-1 and induce the expression of 
new synthesized Hsps. In this study we 
demonstrate that the up-regulation of HO-1 
upon proteasome inhibition is mediated by 
p38MAPK and Nrf-2. Interestingly we found 
additional evidence, proving the involvement 
of HDAC6 in the up-regulation of HO-1. By 
using RNAi technologies against HDAC6 we 
demonstrate that there is a lack of the 
expected induction of HO-1, Nrf-2 and 
phosphorylated p38 (pp38) after proteasome 
inhibition. Furthermore, we can show, that 
p38 is acetylated in unstressed cells and is a 
good substrate for HDAC6 mediated 
deacetylation. Therefore we propose that 
upon proteasome inhibition HDAC6 
deacetylates p38, allowing the following 
phosphorylation of p38 and the consequently 
activation of NRF-2. NRF-2 enters the nucleus 
and functions as a transcription factor for 
HO-1. 
 
Maintenance of cellular protein homeostasis is 
mainly mediated by autophagy, heat shock 
proteins and the proteasome. The proteasome is a 
cylindrical shaped, multicatalytic protease 
consisting of a 20S “core” structure and some 
regulation units, including the 11S and the 19S 
proteasome subunit. The complex of two 19S 
regulators with one 20S core structure builds the 
26S proteasome, which is responsible for the 
ATP-dependent degradation of ubiquitinated 
proteins (1).  
Ubiquitin is a highly conserved, small protein 
consisting of 76 amino acids (2). 
Polyubiquitination of proteins, which comprises 
at least 4 ubiquitin molecules, is mediated by 
three different sets of distinct enzymes in an 
ATP-dependent manner. The ubiquitin activating 
enzyme (E1) binds in a first step one molecule of 
ubiquitin at its C-terminal glycine. In a second 
step the bound ubiquitin molecule is transferred 
to an ubiquitin conjugating enzyme (E2). The 
third step comprises complex formation of the 
substrate protein, the E2 enzyme with the bound 
ubiquitin and one of the several E3 ubiquitin 
ligases. Depending on the type of the 
participating E3 ubiquitin ligase, ubiquitin is 
either tagged directly to the substrate or 
indirectly in a two-step mechanism (3). 
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Ubiquitin-depended degradation by the 
proteasomal system concerns mainly the large 
spectrum of short-lived-, regulatory-, onco- and 
structural proteins (4).  
Inhibition of the proteasome leads to an 
accumulation of undegraded, ubiquitinated 
proteins (5). Trying to compensate the 
proteolysis of ubiquitinated proteins by the 
proteasome, there is an up-regulation of the heat 
shock response system, including heat shock 
factor 1 (HSF1), Hsp27 and Hsp70 (6;7). In 
2007, Boyault et al. demonstrated that the class 
two histone deacetylase HDAC6 functions as a 
linker molecule between accumulating 
ubiquitinated proteins and the induction of heat 
shock proteins after proteasome inhibition (6). 
Moreover, it was observed in several studies that 
heme oxygenase 1 (HO-1), which is also known 
as Hsp32, is also up-regulated after proteasome 
inhibition (8;9). Interestingly, HO-1 does not 
participate in protein binding or stabilization, but 
rather functions as a potent antioxidant and anit-
inflammatory protein, promoting general cell 
survival upon cellular stress (10). Induction of 
hmox1 gene transcription is mainly connected to 
the transcription factor nuclear factor (erythroid-
derived 2)-like 2 (Nrf-2), which binds to several 
stress response elements (StREs) at the hmox1 
promotor region (10). In unstressed cells NRF-2 
is suppressed by Kelch-like ECH-associated 
protein 1 (Keap-1) and trapped in the cytosol 
(10). Upon cellular stress NRF-2 dissociates 
from Keap-1 and translocates into the nucleus. 
Dissociation and activation of NRF-2 is 
mediated by phosphorylation, which involves 
different kinases, such as protein kinase C 
(PKC), phosphoinositol-3-kinase (PI3K) or 
MAPK (11).  
In the present study we show that induction of 
HO-1 upon proteasome inhibition is mediated by 
p38-MAPK-dependent activation of NRF-2. 
Furthermore, we demonstrate that HDAC6 is not 
only necessary to activate the “classical” 
chaperone response, but rather HDAC6 is also 
involved in the p38-dependent induction of HO-
1 after proteasome inhibition.  
 
Experimental procedure 
Cell Culture and cell treatment - Human 
foreskin fibroblast (a kind gift from Dr. 
Wlaschek, University of Ulm), WM451Lu 
melanoma cells, HT29 colon carcinoma cells 
were cultured in Dulbecco’s modified Eagel’s 
medium, fortified with penicillin 
(100units/ml)/streptomycin (100µg/ml), 10% 
fetal calf serum and 1% Glutamax and K562 
chronic myelogenous leukemia cells were 
cultured in RPMI medium fortified with 10% 
fetal calf serum in a humidified atmosphere of 
5% CO2 at 37°C. Experiments were conducted 
with cells of passage 14-22. For siRNA 
transfection it was used either medium without 
penicillin/streptomycin or serum-free medium 
without penicillin/streptomycin. For inhibition of 
the proteasome it was used 20µM Lactacystin 
(LC) (Sigma-Aldrich, Germany) with 0.5h or 
16h pre-incubation. The MAPK/p38 inhibitor 
SB203580 (Merck, Calbiochem) was diluted in 
DMSO and added to the culture medium 0.5h 
before LC application. Final concentration of 
SB203580 was 5µM (0.19% DMSO).  
siRNA-Transfection - RNAi experiments 
were conducted with ON-TARGET plus smart 
pool siRNAs (Thermo Scientific/Dharmacon). 
ON-Target plus smart pool siRNA is a pool of 
four different siRNAs against one target with 
reduced off-target effects. For siRNA 
transfection, cells were seeded with antibiotic-
free medium. Preparation and dilution of the 
used siRNA were carried out according to the 
manufactures instructions. Final siRNA 
concentration was 25nM. siRNA delivery was 
mediated by DharmaFECT-reagent 1 (Thermo 
Scientific/Dharmacon). siRNA were used for the 
knock-down of HDAC6 mRNA and ubiquitin 
activating enzyme E1 mRNA. Sequences of 
smart pool siRNA for HDAC6 are: (i) GGG 
AGG UUC UUG UGA GAUC, (ii) GGA GGG 
UCC UUA UCG UAGA, (iii) GCA GUU AAA 
UGA AUU CCAU and (iv) GUU CAC AGC 
CUA GAA UAUA. Sequences for E1 siRNA 
are: (i) GAA GUC AAA UCU GAA UCGA, (ii) 
CCA CAU AUC CGG GUG ACAA, (iii) CCU 
UAU ACC UUU AGC AUCA and (iv) GCG 
UGG AGA UCG UAA GAA. Following siRNA 
sequences were used for p38 (MAPK14): (i) 
GGA AUU CAA UGA UGU GUAU, (ii) UCU 
CCG AGG UCU AAA GUAU, (iii) GUA AUC 
UAG CUG UGA AUGA, (iv) GUC CAU CAU 
UCA UGC GAAA. siRNA sequences for Nrf-2 
are: (i) UAA AGU GGC UGC UCA GAAU, (ii) 
GAG UUA CAG UGU CUU AAUA, (iii) UGG 
AGU AAG UCG AGA AGUA, (iv) CAC CUU 
AUA UCU CGA AGUU. As a control for 
unspecific siRNA effects we used scrambled 
siRNA (non targeting siRNA pool; D-001810-
10-05) as a negative control.  
Quantitative PCR analysis - After 
treatment with 20µM LC, total mRNA was 
isolated with the Qiagen RNeasy Mini Kit 
(QIAGEN, Hilden). Only mRNA with RNA 
integrity > 9 was used for further experiments. 
3 
Concentration and purity of mRNA was 
determined by a Nanodrop ND-1000 
Spectrometer (peq LAB Biosciences, Erlangen). 
cDNA synthesis was performed with Superscript 
II reverse transcriptase (Invitrogen). Quantitative 
real-time PCR was conducted using a Bio-Rad 
IQ-iCycler and the Bio-Rad IQ SYBR Green 
Super-Mix. Primer sequences used in this work 
were as follows: human HSP27 forward, CTG 
CAA AAT CCG ATG AGA CT; human HSP27 
reverse: ACA GGT GGT TGC TTT GAA CTT; 
human HMOX1 forward: GGT GAT AGA AGA 
GGC CAA GAC; human HMOX1 reverse, CCA 
CCA GAA AGC TGA GTG TAA; human 
HSPA1A forward: CCA TGA CGA AAG ACA 
ACA ATC; human HSPA1A reverse, GTC CTC 
CGC TTT GTA CTT CTC. As housekeeping 
genes for relative mRNA quantification beta 
actin and GAPDH were chosen; human beta 
actin forward, AGG ATG CAG AAG GAG ATC 
ACT; human beta actin reverse, AAG AAA 
GGG TGT AAC GCA ACT; human GAPDH 
forward, GGG TGT GAA CCA TGA GAA 
GTA; human GAPDH reverse, GTC CTT CCA 
CGA TAC CAA AGT.  
Immunoblot Analysis - Cells were lysed 
at 4°C with SDS-Lysisbuffer containing 10mM 
TRIS-HCl (pH7.5), 1mM Pefabloc, 0.9% 
Nonidet P40 and 0.1% SDS. Protein 
concentrations of the samples were determined 
according to Lowry (12). 20µg of total protein 
were denatured at 95°C for 5min in reducing 
Laemmli Buffer (0.25M TRIS (pH6.8), 8% SDS, 
40% glycerol and 0.03% Orange G). Samples 
were separated with 10% (w/v) acrylamide, 
followed by blotting on nitrocellulose according 
to standard procedures. Detection of the 
membranes was conducted with the Odyssey 
infrared detection system from LI-COR (LI-COR 
Biosciences, Bad Homburg). Blot evaluation was 
conducted with Odyssey Application Software 
Version 3.0 from Li-Cor. Following primary 
antibodies were used: ms anti Hsp70 (ab6535), 
ms anti Hsp27 (ab2790), ms anti HO-1 
(ab13248), rb anti NRF-2 (ab62352), ms anti 
HDAC6 (ab56926), rb anti E1 ubiquitin 
activating enzyme (ab96737), ms anti GAPDH 
(ab8245), ms anti p38 (ab31828), rb anti 
phosphorylated p38 (ab32557), goat anti 
aspartate amino transferase (ab85857) (abcam, 
Cambridge, UK) and rb anti PARP(9542L) and 
rb anti acetyl-lysine (9441S) (Cell Signalling, 
Boston) 
Determination of ROS with 2,7-
dichlorofluorescin diacetate (DCF) – Cells were 
incubated 45 min with 5µM DCF, diluted in 99% 
ethanol, before they were harvested with 1x 
trypsin. For immediate treatment with 1mM 
H2O2, DCF was given 45 min before H2O2 
application. Detection of DCF fluorescence was 
carried out, using black 96-well plates (Nunc, 
Denmark) and a 96-well plate reader (ex 485nm, 
em 528nm) 
MTT Viability assay – Cell viability after 
proteasome inhibition and/or treatment with 
E1/HDAC6 siRNA was determined with a MTT-
viability assay (Carl Roth). After cell treatment 
normal growth media was exchanged by MTT 
solution (10mg/ml) and incubated for 1.5 h at 
37°C and 5% CO2. Thereafter MTT solution was 
discarded and cells were lysed using DMSO 
containing 10% SDS and 0.6% acetic acid. 
Viability was determined photometric at a 
wavelength of 580nm (reference: 660nm) 
Confocal laser scanning microscopy - 
Cells were seeded into small glass bottom dishes 
(diameter 35mm). After the indicated treatment 
cells were washed twice with PBS, fixed with 
ethanol/diethyl ether (1/1) and blocked with 1% 
FCS. Following the blocking step, cells were 
treated with 0.1% Triton X-100 for 5 min and 
incubated with primary antibodies (rb anti NRF-
2, ab31163, abcam) at 4°C over night. As 
secondary antibodies we used “goat anti rabbit 
Alexa Fluor 546nm-conjugated”.Immediately 
before cells were used for microscopy, cell 
nuclei were stained with 10µM DAPI. Pictures 
were made with a LSM710 from Carl Zeiss (Carl 
Zeiss, Germany). 
Isolation of nucleus fraction- Cells were 
washed twice with PBS and harvested with 
trypsine. After centrifugation, the supernatant 
was discarded and cell pellets were diluted in 
buffer A, containing 10mM Hepes (pH7.9), 10 
mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 µM 
DTT, 1 µM sodium orthovandate and 1x 
protease inhibitor cocktail “complete Mini” 
(Roche Diagnostics, Mannheim). After 45 min 
incubation on ice, samples were treated with 
Nonidet P40, vortexed and centrifuged. The 
supernatant was isolated as cytosolic fraction and 
pellet was diluted in buffer B, which consists of 
20 mM Hepes (pH 7.9), 0.4 M NaCl, 1 mM 
EDTA, 1 mM EGTA, 1 µM DTT, 1 µM sodium 
orthovandate and 1x protease inhibitor cocktail 
“complete Mini” (Roche Diagnostics, 
Mannheim). Incubation time of 15 min was 
disrupted by vortexing and followed by 
centrifugation. The supernatant was used as 
nuclear fraction. 
HDAC6 activity assay –Isolated HDAC6 
was purchased from Calbiochem (Merck-
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Calbiochem, Germany) and its activity was 
measured with a colorimetric HDAC Assay Kit 
from Millipore (Merck-Millipore, Germany). 
The assay was executed according to the 
manufacturer’s protocol. HDAC6 activity was 
measured with 77.1U, 154.2U, .308.4U, 616.8U 
and 1233.6U. HDAC activity of cell culture 
samples was conducted with whole cell lysate. 
p38 deacetylation assay and 
immunoprecipitation - Cell lysates were 
harvested as it is described in the “immunoblot 
analysis” -section. Immunoprecipitation was 
conducted with the “Immunoprecipitation Kit-
Dynabeads Protein G” from invitrogen 
(Invitrogen Dynal, Norway). The samples were 
either incubated with HDAC6 (771 units) before 
or after immunoprecipitation with ms anti p38 
(abcam, ab31828) antibody. HDAC6 incubation 
was conducted for 60 min at 37°C. 
p38 activity assay – To determine the 
activity of p38MAPK of treated and untreated 
cells, p38 was first isolated by 
immunoprecipitation like it was mentioned 
before. The activity of immunoprecipitated p38 
was then detected by the “Z´-Lyte Kinase Assay 
Kit-Ser/Thr 4 Peptide” from invitrogen 
(invitrogen, Carlsbad, CA). The assay was 
conducted according to the manufacturer’s 
manual.  
Results 
Expression of heat shock proteins after 
proteasome inhibition – To confirm the recent 
findings of the literature, we verified the 
augmentation of Hsps following proteasome 
inhibition via RT-qPCR analysis and western 
blot detection. The samples of figure 1 show 
protein (A) and RNA (B) expression of HO-1, 
Hsp27 and Hsp70 after 0.5h or 16h LC 
incubation. Treatment with LC for 0.5h does not 
lead to a significant increase of all three 
observed Hsp proteins, neither at the state of 
mRNA-expression nor at protein levels. In 
contrast, incubation for 16h with LC results in a 
high significant augmentation of HO-1 gene 
expression compared to the control (Fig.1B). The 
significant increase of HO-1 with 16h LC 
treatment is also detectable at protein levels, 
where the LC treated sample has an 8-fold higher 
HO-1 protein expression than the control 
(Fig.1A). The observations for Hsp70 expression 
are similar. 16h LC incubation results in a drastic 
and high significant increase of Hsp70 mRNA 
expression and Hsp70 protein content compared 
to the control (Fig.1). For Hsp27 it was also 
observed that mRNA levels enhance 
significantly after 16h LC treatment, certainly 
the augmentation of Hsp27 protein content is not 
significant. 
Gene silencing of HDAC6 and E1 
ubiquitin activating enzyme –Before we tested 
the effects of polyubiquitination and HDAC6 on 
Hsp induction, we proved whether the used 
siRNAs lead to a significant knockdown of the 
target genes. Cells were treated respectively with 
siRNA for HDAC6, E1 or a scrambled siRNA as 
negative control to exclude side effects by the 
transfection procedure or incorporation of RNA 
into the cell. Gene silencing with siRNA against 
HDAC6 and E1-ubiquitin activating enzyme 
resulted in a significant down-regulation of the 
particular protein (Fig.S1A, Supplemented Data). 
Incorporation of a scrambled siRNA, functioning 
as a negative control, has no effect on HDAC6 or 
E1 protein content/regulation (Fig.S1A, 
Supplemented Data).  
Influence of HDAC6/E1 on Hsp response 
and cell death following proteasome inhibition – 
Previously it was demonstrated that induction of 
Hsps upon proteasome inhibition is mediated by 
the accumulation of ubiquitinated proteins and 
the activation of HDAC6 (6). To verify whether 
this is also true for our cell system, we treated 
cells either with siRNA against HDAC6 or E1 
ubiquitin activating enzyme and inhibited the 
proteasome by treatment with LC for 16h. As it 
is shown in figure 3, induction of Hsp70 after 
proteasome inhibition is indeed significantly 
reduced, when E1 or HDAC6 is knocked down 
(Fig.2A). 
Due to the fact that HO-1 is also up-regulated 
when the proteasome is impaired, we wondered 
if HDAC6 may also play a role in HO-1 
induction and if yes, where in the HO-1 
induction cascade does HDAC6 interfere. Thus, 
we treated cells again with HDAC6/E1 siRNA 
and LC for 16h. Detection of HO-1 protein 
expression demonstrates a high significant 
augmentation of HO-1 after proteasome 
inhibition (Fig. 1 and 2A). Interestingly, pre-
treatment with HDAC6 or E1 siRNA leads to a 
strong decrease in HO-1 expression upon 
proteasome inhibition (Fig. 2A). In addition we 
also detected Nrf-2, p38 and phosphorylated p38 
(pp38) after LC treatment and siRNA 
transfection. Consistent to the results of HO-1, 
Nrf-2 increased also significantly after LC 
treatment. This effect is reduced by about the 
half when cells were transfected with HDAC6 
siRNA. Transfection with E1 siRNA even 
reduces Nrf-2 to one third of single LC 
treatment. (Fig. 2A)  
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pp38 is also enhanced after proteasome 
inhibition, whereas p38 content remains largely 
unaffected. When cells are coincidently 
transfected with either HDAC6- or E1 siRNA to 
LC treatment, pp38 reaches protein levels of 
untreated control cells (Fig. 2A). Treatment with 
scrambled siRNA and coincident inhibition of 
the proteasome results nearly in same protein 
levels than LC alone, indicating again that the 
transfection and incorporation of siRNA evoke 
no random effects (Fig 2A). 
To verify if this effect is not a cell typical 
phenomenon and due to the fact that proteasome 
inhibition is a potent treatment in anti-cancer 
therapies we also tested three different cancer 
cell lines (WM451Lu, K562 and HT29) for 
Hsp70, Ho-1, Nrf-2, p38 and pp38 after 
proteasome inhibition and/or silencing of 
HDAC6 via siRNA (Fig. 2B). In accordance 
with the results of the tested fibroblasts, there is 
also an induction of Hsp70, Ho-1, Nrf-2 and 
pp38 16h after LC treatment in all three cell 
lines. Knockdown of HDAC6 diminishes this 
effect drastically, whereas incorporation of a 
scrambled siRNA has no effects (Fig. 2B).  
To verify the effect of HDAC6 and E1 on cell 
death, we measured cell viability via a MTT- 
viability assay. Compared to an untreated control 
gene silencing of E1 ubiquitin activating enzyme 
or HDAC6 reduce cell viability by about 40%. 
The coincident inhibition of the proteasome with 
LC reduces cell viability again by about 60% 
compared to the control, which means a very 
significant reduction of viable cells compared to 
siRNA alone (Fig. 2C). 
In regard to the western blotting experiments, we 
concluded that HDAC6 is involved in HO-1 
induction upon proteasome inhibition. Further 
on, this seems to be mediated by Nrf-2 and the 
involvement of the p38MAPK pathway.  
Influence of HDAC6 on Nrf-2 after 
proteasome inhibition – When Nrf-2 is activated, 
it translocates from the cytosol into the nucleus 
and binds to StREs of target genes. Due to the 
observed augmentation of Nrf-2 upon 
proteasome inhibition, we wanted to verify if 
Nrf-2 is located in the nucleus after 16h LC 
treatment and if this can be interrupted by 
siHDAC6 treatment. Therefore we incubated 
normal fibroblasts and siHDAC6 transfected 
fibroblasts with LC for 16h. Following the 
incubation time we separated the nucleic fraction 
from the cytosol and used the two fractions for 
western blot detection. As expected, there is a 
strong accumulation of Nrf-2 in the nucleus 
fraction after proteasome inhibition (Fig. 3A), 
leading to a high significant increase compared 
to the control. When cells were additionally 
treated with HDAC6 siRNA, Nrf-2 content 
diminishes more than a half in the nucleus 
fraction and is comparable to the protein levels 
of the untreated control (Fig. 3A). The amount of 
Nrf-2 in the cytosolic fraction remains consistent 
at low levels and shows no clear differences 
between the different treatments (Fig. 3A). 
Further evidence for Nrf-2 translocation into the 
nucleus upon LC treatment and its attenuation by 
HDAC6 inhibition is given by Figure 4. There it 
is visualized by confocal laser scan microscopy 
that Nrf-2 clearly accumulates in the nucleus 
after proteasome inhibition and exceeds in total 
amount of Nrf-2 compared to the control and to 
the cells treated with HDAC6 siRNA (Fig. 4). 
To exclude that Nrf-2 is mainly activated 
by oxidative stress after proteasome inhibition, 
we detected ROS levels after LC treatment and 
as a comparison hydrogen peroxide (H2O2). In 
Figure 3B it is shown that the generation of ROS 
after proteasome inhibition is nearly at the same 
levels than the controls. Moreover, treatment 
with 1mM H2O2 for 0.5 h and 16h recovery time 
has also only low effects in ROS generation and 
reaches the same levels than the control or 
treated with LC. Contrarily, generation of ROS 
increases eight fold immediately after the 
incubation for 0.5 h with 1 mM H2O2 (Fig. 3B). 
 
The role of p38 in Nrf-2/HO-1 activation 
after proteasome inhibition – In Figure 2 it was 
demonstrated that p38MAPK is also activated 
upon proteasome inhibition, resulting in the 
phosphorylation of p38 (Fig. 2A/B). To prove 
whether p38 is involved in Nrf-2 and HO-1 
signaling, we treated cells with the well known 
p38MAPK inhibitor SB203580 in combination 
with proteasome inhibition. Due to the fact that 
SB203580 is diluted in DMSO, the control group 
was treated with same volumes of DMSO or 
DMSO and LC. Compared to the DMSO control, 
treatment with 5µM SB203580 leads to a 
significant decrease of Nrf-2 expression (Fig 
5A). In consistence with this down regulation of 
Nrf-2, HO-1 expression is also drastically 
attenuated after p38MAPK inhibition, resulting 
in a 4-fold reduction of HO-1 in SB203580 
samples compared to the samples with DMSO + 
LC. Treatment with DMSO or SB203580 alone 
has no remarkable effects on NRF-2 or HO-1 
expression. As it is demonstrated, application of 
5 µM SB203580 or the corresponding volume of 
DMSO has no effects on protein expression of 
total p38 (Fig. 5A). Although, SB203580 is a 
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specific inhibitor of the kinase activity of p38 
(8;13;14) , it seems to have also some influence 
on the phosphorylation level of p38, even if this 
effect is not significant (Fig 5). Possibly this is 
the result of the inhibition of p38 auto-
phosphorylation. 
To control the results with the p38 
inhibitor SB203580, we also silenced p38 and 
Nrf-2 with RNAi technology. The knockdown of 
p38 and Nrf-2 with siRNA is clearly 
demonstrated in Figure 5B. As it is depicted, 
silencing of p38 retards the induction of Nrf-2 
and HO-1 after LC treatment (Fig. 5B), which 
confirms the results of the pharmacological 
inhibition of p38. Silencing of Nrf-2 with a 
siRNA also inhibits the induction of HO-1 after 
proteasome inhibition with LC, demonstrating its 
involvement in the induction of HO-1 (Fig. 5B). 
Summarizing the results of p38MAPK inhibition 
upon LC treatment, it seems evident that p38 
plays a crucial role in NRF-2 activation and HO-
1 induction in response to proteasome inhibition. 
In regard to this results and the influence of 
HDAC6 to Nrf-2, HO-1 and phosphorylated p38, 
we hypothesized that HDAC6 interacts directly 
with p38 after proteasome inhibition. 
Interaction of HDAC6 with p38 upon 
proteasome inhibition – There are two 
possibilities how HDAC6 influencing the 
activation of p38 upon proteasome inhibition: 
Either HDAC6 interferes with an up-stream p38 
activator or HDAC6 deacetylates p38 directly, 
facilitating its phosphorylation and activation. 
Therefore p38 of untreated cells was isolated by 
immunoprecipitation (IP) and detected for p38 
and acetylation status by western blotting. As it 
is depicted in Figure 6, p38 is clearly acetylated 
under unstressed conditions (Fig. 6A). 
Interestingly, when the proteasome is inhibited 
by LC, p38 shows no acetylation pattern in the 
IP-fraction. Further on, this effect can be 
abolished if LC treatment is accompanied with 
the HDAC6 siRNA (Fig. 6A). To clarify if 
acetylated p38 is really a substrate of HDAC6, 
we incubated either the whole fibroblast cell 
lysate with pure HDAC6, followed by an IP of 
p38 or we incubated isolated p38 with HDAC6 
following an IP of p38. By detection of the 
acetylation status of the IP-fractions, it becomes 
obvious that acetylated p38 can be deacetylated 
by HDAC6. Incubation of isolated p38 with 
HDAC6 results in a total loss of acetyl at p38, 
whereas the unbound fraction of this IP shows 
still acetylated proteins (Fig. 6A). Previous 
incubation of the fibroblast cell lysates with 
HDAC6 before the IP results also in a drastic 
decrease of p38 acetylation. The unbound 
fraction of this approach still contains some 
acetylated proteins, indicating that not all 
acetylated proteins are substrates of HDAC6 (Fig 
6A). We also incubated the whole cell lysate and 
the immunoprecipitated p38 with pure HDAC1, 
to check whether deacetylation of p38 is a 
specific feature of HDAC6 or an unspecific 
effect, which can be achieved by any HDAC. As 
it is depicted in Figure 6, incubation with 
HDAC1 has only weak to no effects regarding 
deacetylation of p38 (Fig 6A), showing a certain 
specificity of p38 as a substrate of HDAC6 
dependent deacetylation. 
To guarantee the specific deacetylation 
activity of the used HDAC6, increasing contents 
of the used HDAC6 were tested in a standardized 
HDAC activity assay. Thereby, resulted 
increasing amounts of HDAC6 in an increasing 
amount of deacetylated substrate, proving the 
functionality of the isolated HDAC6 
(Supplemented data, Fig. S1B).  
 In regard to our theory there must be a 
measurable effect of HDAC activity and p38 
activity after the inhibition of the proteasome 
and/or the involvement of HDAC6 siRNA and 
isolated HDAC6. Therefore we detected the 
HDAC activity and p38 activity after proteasome 
inhibition. Cell treatment with LC results in an 
increase of HDAC activity and a coincident 
augmentation of p38 activity by about 10% 
compared to the control (Fig 6B/C). Although 
HDAC activity was measured in whole cell 
lysates where it is difficult to measure drastic 
effects of HDAC activity due to the presence of 
all other HDACs, it is all the more impressive 
that silencing of HDAC6 via siRNA with 
coincident LC treatment results in a 25% 
reduction of HDAC activity compared to the 
control and a 37% reduction compared to the 
single LC treatment (Fig.6B). 
As it was mentioned inhibition of the 
proteasome results also in an increase (~10%) of 
the activity of immunoprecipitated p38 compared 
to the untreated control (Fig. 6C). Nearly same 
effects are achieved when the 
immunoprecipitated p38 was incubated for one 
hour with pure HDAC6 (Fig. 6C). 
 
Discussion 
In the present study we demonstrate that 
inhibition of the proteasome by LC causes an 
induction of “classical” heat shock proteins and 
HO-1 (Fig.1). Moreover, we show that HDAC6 
plays a central role in the coordination of the 
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induction of these two systems, which follows 
two different activation pathways. 
Up-regulation of classical Hsps upon proteasome 
inhibition has been observed in several other 
studies before (6;15-17). Due to the impairment 
of the proteasome it is crucial to compensate the 
disrupted proteolysis of (ubiquitinated) proteins 
by binding and stabilizing these proteins, 
preventing protein aggregation and apoptosis 
(6;15-17). We also could show that elevation of 
Hsps upon proteasome inhibition is mediated by 
an enhancement of Hsp mRNA (Fig. 1), 
indicating a de novo synthesis of heat shock 
proteins and the preceded liberation and 
activation of HSF1, which is absolutely 
necessary for Hsp gene transcription (18). This is 
consistent with the results of Boyault et al. (6) 
and Wu et al. (8) which also demonstrated that 
there is a de novo synthesis of heat shock 
proteins after proteasome inhibitor treatment. It 
was also shown in the work of Boyault et al. that 
activation of HSF1 and induction of the 
chaperone response is initiated by HDAC6 after 
proteasome inhibition. Thereby, in unstressed 
cells, HDAC6 is involved in a complex with 
Hsp90, p97/VCP and HSF1, keeping HSF1 in an 
inactive, monomeric state. Upon proteasome 
inhibition HDAC6 binds accumulated, 
ubiquitinated proteins, leading to a dissociation 
of the complex and liberation of HSF1(6). Free 
HSF1 builds homotrimers in the cytosol and 
translocates into the nucleus, where HSF1 binds 
to heat shock elements (HSEs) of distinct target 
genes, like Hsp27 or Hsp70 (19) (Fig. 7). By 
gene silencing of either HDAC6 or E1 ubiquitin 
activating enzyme, we observed drastic decrease 
of the Hsp70 response after LC treatment (Fig 2), 
confirming the essential role of HDAC6 in Hsp 
activation upon proteasome inhibition. 
Besides, the classical Hsps we also find 
enhanced levels of HO-1 mRNA and proteins 
after 16h LC treatment. Evidence from several 
studies has indicated that HO-1 elevation during 
proteasome inhibition is mediated by Nrf-2 and 
the activation of p38-MAPK pathway (8;20;21). 
Nrf-2 is a unique stress response transcription 
factor, involved in the induction of a variety of 
genes encoding for proteins, participating in the 
detoxification and metabolism of xenobiotics and 
oxidative stress response (22). Nrf-2 binds to 
StREs of target genes, which are also frequently 
found in the promotor region of HO-1 (10). 
Activation of Nrf-2 is mediated by a large 
variety of different kinases, such as protein 
kinase C (PKC), phosphoinositol-3-kinase 
(PI3K) or MAPK (11). Especially the p38-
MAPK pathway seems to be an important 
activator of Nrf-2 in case of proteasome 
inhibition. Moreover the effect is independent 
from the used proteasome inhibitor. Studies with 
MG132 (8;20) or bortezomib (20;23) show 
similar results than we observed with LC. In all 
these studies it was suggested that p38-related 
activation of Nrf-2 is integrated in an anti-
apoptotic response upon proteasome inhibition. 
Moreover, it can also be excluded that Nrf-2 is 
induced by oxidative stress after proteasome 
inhibition, due to the fact that 16h incubation 
with LC results in no remarkable elevation of 
oxidative stress (Fig. 3).  
This fits very well with the anti-
apoptotic properties of up-regulated HO-1. HO-1 
cleaves its substrate heme into Fe2+, biliverdin 
and carbon monoxide (CO) (24). Fe2+, which is 
itself a high inducer of oxidative stress by 
employing the Fenton reaction (25), results in a 
compensating induction of ferritin and Fe-
ATPase, functioning as an anti-oxidant and 
diminishing the amount of intracellular iron (24). 
The second reaction product, biliverdin, is 
immediately metabolized to bilirubin, which is 
also a strong anti-oxidant, scavenging peroxyl-
radicals and diminishing membrane peroxidation 
(26). The anti-inflammatory and anti-apoptotic 
effects of HO-1 are mainly mediated by CO, 
acting as a second messenger. CO eases the 
expression of pro-inflammatory cytokines like 
TNF-α, IL-1β and MIP-1β and promotes the up-
regulation of anti-inflammatory cytokines such 
as IL-10 (27).Further on, it was demonstrated 
that the increase of HO-1-related CO could 
suppress TNF-α mediated apoptotic cell death in 
endothelial cells after actinomycine D treatment 
(28). In addition it was observed that enhanced 
HO-1/CO expression lowering apoptotic tumor 
cell death by inhibition of p53 expression and 
blockage of mitochondrial cytochrome c release, 
during anti-tumor therapies (29). 
Disruption of p38-MAPK activity by 
SB203580 or RNAi leads to a coincident 
breakdown of Nrf-2 and HO-1 expression (Fig. 
5), which is another evidence for their 
dependency on the p38-MAPK pathway and in 
accordance with other groups, showing also a 
p38MAPK-dependency of Nrf-2 and HO-1 
induction (8;14;20). Interestingly we found 
similar effects when we decreased the 
accumulation of ubiquitinated proteins or the 
expression of HDAC6 by RNAi technologies. 
siRNA against HDAC6 resulted in a drastic 
attenuation of p38 phosphorylation after 
proteasome inhibition. Further on we 
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demonstrated that p38, which is acetylated in 
unstressed cells, is a proper substrate for 
HDAC6-related deacetylation (Fig. 7B). Due to 
this we suggest a direct interaction of HDAC6 
and p38 during accumulation of 
polyubiquitinated proteins, where HDAC6 
deacetylates p38 and facilitates therefore the 
phosphorylation of p38. Moreover, 
phosphorylated p38 leads to the phosphorylation 
of Nrf-2, which dissociates consequently from 
Keap-1 and translocates into the nucleus, 
resulting in the transcription of Nrf-2 target 
genes, such as HO-1 (Fig. 7). 
Because the proteasomal system is an 
integral part for the cellular protein homeostasis, 
it became a promising target in cancer therapy. 
The efficiency of single bortezomib application 
as a specific proteasome inhibitor was tested in 
many clinical trials, such as the SUMMIT-, 
CREST- and APEX trial (30-32). Nevertheless, 
success of this therapy is attenuated since cancer 
cells exhibit a resistance to bortezomib treatment 
(33). So far, it has been suggested that the 
compensational elevation of Hsps (6) and 
aggresome formation (34) in cancer cells are 
responsible for the diminished efficiency of 
proteasome inhibition in anti-tumor therapies 
(35). Both, the Hsp induction and aggresome 
formation, are coordinated by the activation of 
HDAC6 upon proteasome inhibition (6;34). In 
regard to our findings, the elevation of Nrf-2 and 
HO-1 is also a HDAC6 coordinated survival 
mechanism during proteasome inhibition, which 
could impair the efficiency of bortezomib 
treatment. To overcome the resistance to 
bortezomib, there are some recent trials, where 
proteasome inhibition is combined with HDAC 
class I and II inhibitors, resulting in an elevation 
of ROS, mitochondrial injury, caspase activation 
and apoptosis (36-38). Due to the fact that the 
three cancer cell lines tested in our study also 
show equal protein expression pattern after 
proteasome inhibition and/or HDAC6 knock-
down than the tested fibroblasts (Fig. 2B), it 
should be promising to combine proteasome and 
HDAC6 inhibition. 
Taken together this study demonstrates 
the involvement of HDAC6 in proteasome 
inhibition related induction of Nrf-2 and HO-1 
and elucidates the crucial function of HDAC6 for 
protein homeostasis. 
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Abbreviations  
DAPI    4′,6-diamidino-2-phenylindole 
DCF    2′,7′-dichlorofluorescein 
DMSO    dimethyl sulfoxide 
EDTA    ethylenediaminetetraacetic acid 
EGTA    ethyleneglycoltetraacetic acid 
FCS    fetal calf serum 
GAPDH   glyceraldehyde 3-phosphate dehydrogenase 
HO-1    heme oxygenase-1 
Hsp    heat shock protein 
Keap-1    Kelch-like ECH-associated protein 1 
NRF-2    nuclear factor (erythroid-derived 2)-like 2 
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FIGURE LEGENDS 
FIGURE 1. Induction of Hsps 0.5h and 16h after proteasome inhibition. Cells were cultured 
as described in “Experimental procedure” and treated with LC for 0.5h or 16h. Following the 
indicated incubation times total cell lysates or RNA were used for western blot- or RT-qPCR 
analysis. A) Representative western blots of HO-1, Hsp27 and Hsp70 and the related GAPDH 
blots of three independent experiments are depicted. Panel B) are the results of RT-qPCR. 
mRNA expression of target genes is adjusted to house-keeping genes and referred to the 
particular controls. A) and B) are means ± SD; n=3;*p<0.05,**p<0.01 versus untreated 
control; unpaired t-test. 
 
FIGURE 2 Role of ubiquitination/HDAC6 in HO-1 induction during proteasome inhibition. 
Cells were cultivated, transfected and blotted as described in “Experimental procedure”. 
Proteasome was inhibited with 20µM lactacystin (LC). A) Depicted western blots are an 
example of three independent experiments with human dermal FF95 fibroblasts. B) The 
shown western blots are examples of two independent experiments of three different cancer 
cell lines: WM451L melanoma cells, K562 chronic myelogenous leukemia cells and HT29 colon 
cancer cells. C) MTT-viability assay of LC and siRNA treated cells. Relative values are compared to 
the control. Columns are means ± SD, n=3, #p<0.001 versus control, *p<0.05, **p<0.01 versus 
siRNA treated cells, ANOVA, Tukey’s post test. 
 
FIGURE 3 A) Translocation of Nrf-2 into the nucleus after proteasome inhibition. Cells were 
incubated with LC for 16h. Separation of cytosolic and nucleic fraction was conducted like it 
is mentioned in “Experimental procedure”. To verify the two fractions, poly(ADP-
ribose)polymerase (PARP) was used to identify the nucleic fraction and aspartat-amino-
transferase (ASAT) for cytosolic fraction. Columns are means ± SD of 4 independent 
experiments. #<0.01 versus control, *<0.05 versus siHDAC6+LC, ANOVA, Tukey’s post 
test. B) Detection of ROS levels after LC treatment with DCF. Cells were incubated for 16h 
with LC and then used for DCF assay. Cells treated with 1mM H2O2 were either taken for 
DCF assay immediately after 0.5h incubation with H2O2 or they recovered 16h in normal 
growth medium before they were harvested for DCF assay. Columns are means ± SD of 3 
independent experiments. 
 
FIGURE 4 Visualization of Nrf-2 translocation into the nucleus after proteasome inhibition 
and HDAC6 siRNA treatment. Nucleus is depicted in red (DAPI) and Nrf-2 is presented in 
green (AlexaFluor546). Yellow areas represent the co-localization of Nrf-2 with the nucleus. 
 
FIGURE 5 Influence of p38MAPK activity on HO-1 induction after proteasome inhibition. A) Cells 
were pre-incubated with 5µM SB203580 for 30min. After that, 20µM LC was added for additional 
16h. Depicted are representative Western blots of four individual experiments. Columns are means ± 
14 
SD; n=4; *p<0.05; ***p<0.001, versus SB203580 treatment; unpaired students t-test. B) Verification 
of the role of p38 and Nrf-2 in HO-1 induction after proteasome inhibition. Cell treatment and siRNA 
transfection were conducted like it is mentioned in “Experimental Procedures”.  
FIGURE 6 Influence of HDAC6 on immunoprecipitated p38. A) Cell lysates were either pre-
incubated before the IP with LC / LC+siRNA HDAC6 / HDAC6 / HDAC1 (column 2/3/5/7) or first 
immunoprecipitated with p38 and then incubated with HDAC6/HDAC1 (column 4/6). The control 
(column 1) remained untreated and was also immunoprecipitated with p38 like it is described in 
“Experimental procedure”. UF = unbound fraction; IP = immunoprecipitation fraction. B) Detection of 
HDAC activity after proteasome inhibition and the influence of HDAC6 siRNA. Cell treatment and 
HDAC activity assay was conducted like it is explained in “Experimental Procedures”. Columns are 
means ± SD C) Measurement of p38 activity after proteasome inhibition and the role of HDAC6. 
After cell treatment, cells were immunoprecipitated with a p38 antibody. Isolated p38 was then used 
for the kinase activity assay. Incubation with pure HDAC6 lasted 1h. Columns are means ± SD 
 
FIGURE 7 Schematic depiction of the role of HDAC6 on Hsp-regulation upon proteasome inhibition. 
As a consequence of proteasome inhibition there is an accumulation of polyubiquitinated proteins. 
HDAC& detects these ubiquitinated proteins by its ubiquitin-binding domain, leading to the 
dissociation of a complex which composes p97/VCP, Hsp90, HSF-1 and HDAC6 (6).Before HSF-1 
enters the nucleus, the HSF-1 monomers trimerize and become phosphorylated. In the nucleus HSF-1 
enables the transduction of “classical” Hsp-genes. Following deacetylation by HDAC6, p38 becomes 
phosphorylated and activates NRF-2, dissociating from Keap-1. Phosphorylated Nrf-2 enters the 
nucleus and induces the transduction of HO-1.  
 
FIGURE S1 A) Validation of HDAC6- and E1 ubiquitin activating enzyme siRNA 
transfection. Transfection of fibroblasts was conducted like it is mentioned in “Experimental 
Procedure”. One representative example of HDAC6 and E1 western blots with corresponding 
GAPDH blots are depicted after siRNA transfection. Columns are means ± SD of three 
independent experiments. *p<0.05, **p<0.01,one way ANOVA, Tukey’s post test. B) HDAC6 
activity was determined by deacetylation of a colorimetric acetylated HDAC class II substrate. 
Deacetylation of the substrate results in an augmentation of the colorimetric molecule 
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4. Discussion 
4.1 Assessment of protein carbonyls as a marker for oxidative stress 
Since proteins are the most abundant molecules in the cellular system for oxidative 
modifications, there is the interest to quantify and qualify the oxidative damage of 
proteins. The very heterogeneous molecular structure of amino acids and proteins as 
well as different forms of oxidants, the environment, relative location and the 
availability of antioxidative systems, result in a large variety of oxidative protein 
modifications [149]. Many of these oxidative modifications are very special and affects 
only single amino acids, such as the reaction from tryptophan to kynurenine , tyrosine 
residues to dihydroxy derivates or methionine to methionine sulfoxide (MetO) [137]. 
Some of these modifications can easily be repaired, like it was shown for MetO, which 
is repaired by the thioredoxin TR(SH)
2
-dependent methionine sulfoxide reductase [150]. 
Thus, such oxidative modifications are improper markers for protein oxidation, because 
they will decrease over time, sophisticating the result. 
In contrast to the mentioned oxidative modifications, protein carbonyls affect more than 
one special amino acid residue. In Table 1 all amino acids contributing to carbonyl 
modification are listed (Tab. 1). Additionally, protein carbonyls also emerge after 
oxidative cleavage of peptide backbones via the α-amidation pathway [137]. 
 
    Table 1 Amino acids prone to oxidative carbonyl formation 
                (modified from [151]) 
Amino acid residues Carbonyl derivative upon oxidation 
Alanine Acetone 
Valine Formaldehyde 
Leucine Isobutyraldehyde 
Aspartate Glyoxylic acid 
Proline 2-pyrolidone, glutamic semialdehydes 
Arginine Glutamic semialdehydes 
Lysine Aminoadipic semialdehydes  
Histidine Asparagines 
Tryptophan N-formylkynurenine 
 
Several reactive oxygen species like 
•
O2
-
, 
1
O2, H2O2 (reacting with metals, i.e. 
Fe
2+
),HO
•
, ROO
•-
, hypochlorus acid, ONOO
-
 and ozone can directly contribute to the 
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formation of carbonyl groups [152]. But not only primary reactions with oxidants lead 
to protein carbonyls. Secondary reactions of some residues with lipid oxidation products 
(HNE, MDA) or reducing sugars and their reaction products are also reasons for protein 
carbonyl formation [153-155]. 
Due to the fact that protein carbonylation affect nearly 50% of all proteinogenic amino 
acids (Tab.1) and also occurs after oxidative cleavage of peptide backbones it seems to 
be a highly suitable marker for all proteins upon oxidative stress. Moreover, protein 
carbonyls function as markers for primary and secondary oxidation reactions. As it was 
mentioned, protein carbonyls can be measured by different methods. By derivatization 
with 2,4-dinitrophenylhydrazine, protein carbonyls can be detected via western blotting, 
ELISA technique, ICC and IHC, allowing to make a point about the quantity of protein 
carbonyls, the affected proteins and the cellular/histological localization of protein 
carbonyls [151,156]. In regard to this reasons protein carbonyls are a well established, 
frequently used and trustworthy marker for oxidative stress and oxidative modified 
proteins [157-161]. Induction of oxidative stress in WM451Lu melanoma cells by 
application of UV-A irradiation or H2O2 results also in a dose-dependent and time-
dependent increase of protein carbonyls (Publication II and III).  
Since D. Harman postulated the free radical theory of ageing in 1956, it is accepted that 
ROS plays also a important role in the ageing process [162]. Thus, protein carbonyls are 
as well a widely used marker for age dependent protein damage. It was demonstrated 
that there is also an accumulation or protein carbonyls during the ageing process. This 
was shown for rats [163], aging yeast [164], aging nematodes [165] and several human 
tissues [166]. In humans, especially until the age of about 45, protein carbonyls 
accumulate exponentially with increasing life span [167]. 
 
4.2 The usage of siRNA for gene silencing and protein repression 
To examine the role of HDAC6 and ubiquitin in the regulation of proteostasis upon 
proteasome inhibition, translation of these proteins was suppressed via the application 
of siRNA against HDAC6 and ubiquitin activating enzyme E1 (Publication IV). Due to 
the fact that these proteins/genes has already successfully silenced by the application of 
siRNA [168,169] as well as the transfection with shRNA [170,171], it was necessary to 
ponder which the most convenient method is. Due to the usage of vectors and their 
incorporation into the genome, shRNA has the great advantage that the gene-silencing-
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responsible-sequence is stable expressed and suppress the target genes for several 
month. Moreover, the shRNA sequence is passed to daughter cells during cell division, 
guaranteeing an ongoing down regulation of the target genes [172]. Apart from that, 
shRNA transfection, which is normally done by lentiviral transfection, has to be 
conducted in laboratories with biosafety level 2-3. Due to the incorporation of a vector 
into the genome there are also some more difficulties. First, transfection of cells with 
viral vectors takes more time and effort than normal transfection with conventional 
siRNA and needs an additional selection of successfully transfected cells by a 
puromycin assay. Second, integration of viral vectors is a random mechanism. 
Therefore, the efficiency of gene silencing varies significantly depending on the 
integration site into the target genome, which can result in damages of important 
cellular genes [144]. 
Conventional siRNA remains in the cytoplasm after transfection, which precludes any 
interactions with the host genome. However, cells have to be transfected anew for each 
experiment with siRNA. After successful transfection with siRNA, gene silencing 
should be stable for at least 4-5 days. After that period siRNAs degrade over time and 
dilutes by cell division. Thus, stability and silencing efficiency is applicably dependent 
on the proliferation velocity. The experiments of publication IV were done with human 
dermal fibroblast at passage 14-22 (Publication IV). Before transfection with siRNA 
against HDAC6 or E1, cells were seeded out in a way that they reach 80% confluency 
after 2 days, guaranteeing that dilution effects of transfected siRNA via cell 
proliferation is decreased to a minimum. Moreover, due to “contact- and cell density 
inhibition of growth”, human dermal fibroblasts are counted among slow proliferating 
cell lines, which also facilitate the usage of siRNA [173]. Another critical point of gene 
silencing, using siRNA is the occurrence of off-target effects, usually evoked by limited 
target sequence complementation to the siRNA guide strand [174], usage of very high 
concentrations of siRNA [175] or the induction of interferon response [176]. Lin et al. 
demonstrated in a widespread knockdown experiment, examining the involvement of 
kinases in the induction of HIF-1, that all of the “top candidates” resulted from off-
target gene silencing [176]. Interestingly, they also found that some of these 
administered kinase siRNAs contribute directly to the degradation of the Hif-1 RNA. In 
accordance to this, Fedorov et al. investigate the overall consequence of off-target 
effects on cell-physiology [177]. Fedorov et al. conducted as well as Lin et al. [176] a 
large-scale knockdown experiment using 176 randomly selected siRNAs. As a result 
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they demonstrated that off target effects lead to “false positives in broad RNAi-based 
phenotypic screens” and the occurrence of siRNA induced toxicity, resulting in 
apoptosis [178]. The observed siRNA induced off-target effects of this work were 
sequence-dependent, target-independent and relied on the ability to enter the RNAi 
pathway. Interestingly, they could show that chemical modification (2’-O-methyl-
substitution) on position two of the guide strand of the siRNA limit the occurrence of 
off target effects [179] – an effect which was also confirmed by Jackson et al. [180]. An 
additional mechanism concerning the restriction of off-target effects is the use of a pool 
of different siRNA sequences against one target. By the coincident application of 
different siRNA sequences against the same target, the total amount of one specific 
siRNA is decreased on the one side and forms on the other side multiple target regions 
at the mRNA of interest. Avoiding the occurrence of off-target effects, the employed 
siRNA in Publication IV was purchased from Dharmacon RNAi Technologies. They 
offer “ON-TARGETplus SMARTpool” siRNA solutions, combining all the mentioned 
possibilities to decline off-target effects. The used siRNAs for gene silencing of 
HDAC6 and E1 were transfected as a pool made out of 4 different and preselected 
sequences. In addition they possess chemical modifications on both strands (antisense 
and sense), resulting in a blockage of sense strand uptake into the RISC and reduce the 
antisense strand induced off-target effects. 
In a study from Rey et al. repression of HDAC6 in breast cancer cells was also 
conducted with “ON-TARGETplus SMART pool” siRNA from Dharmacon, resulting 
in a significant reduction in HDAC6 expression compared to the control and siRNA 
control [181]. This is absolutely in accordance to the results of Publication IV, using the 
same pool of siRNA sequences (Publications IV). 
 
4.3 The role of the proteasome in oxidative stress – Degradation of oxidative 
modified proteins 
Since the identification and definition of the ubiquitin-proteasomal system, there is an 
ongoing debate about the degradation of oxidative modified proteins. Nevertheless, it is 
undisputed, that the proteasome is responsible for the degradation of the bulk (70-80%) 
of cellular oxidized proteins [182]. The essential question still is whether the majority of 
oxidized proteins become degraded by the 26S proteasome in an ubiquitin- and ATP 
dependent manner or by the 20S proteasome, which is ubiquitin and ATP independent 
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[183]. In Publication II and III it was demonstrated that oxidation of proteins with H2O2 
or UV-irradiation affects nearly the whole content of cellular proteins, whereas 
ubiquitination of proteins occurs only between 250 kDa and 60 kDa (Publication II, 
Publication III, Fig 1A). These results indicate that most proteins are not ubiquitinated 
upon oxidative stress. Therefore, proteins bearing oxidative derived carbonyl groups 
seem not to be preferentially degraded by the 26S proteasome. However, the increase of 
protein carbonyls after H2O2 + inhibition of the proteasome with LC compared with 
single H2O2 treatment point out that these oxidized proteins are degraded by the 
proteasome, which then has to be the ubiquitin independent 20S proteasome 
(Publication III, Fig. 1A).  
There are a multitude of publications supporting the proteasomal degradation of 
oxidative modified proteins in an ubiquitin-/ATP independent way. Already in 1989 the 
group of Davies could demonstrated with isolated 26S and 20S proteasomes that there is 
a preferential degradation of oxidized proteins by the 20S proteasome [184]. Hence, the 
isolated proteasome fractions were incubated with radio labeled hemoglobin (Hb)/ 
oxidized Hb or SOD/oxidized SOD in the absence or presence of ATP/ubiquitin and 
detected for their degradation. As a result they could show that the oxidized forms of the 
proteins were mainly degraded by the 20S proteasome. Degradation of oxidized proteins 
by the 20S proteasome remains nearly unchanged compared to the non-oxidized 
proteins. Interestingly addition of ATP and ubiquitin to the 20S fraction decrease the 
relative amount of degraded oxidized proteins [184].A specific degradation of isolated 
oxidized proteins without the involvement of ubiquitin had been shown in the following 
years for several other proteins, such as calmodulin, ornithine decarboxylase, catalase, 
serum albumin, myoglobin and aconitase [185-187]. In another study from the Davies 
group with E1 mutant ts20 cells, it was shown that despite the lack of a functional 
ubiquitin activating enzyme E1 oxidized proteins had been successfully eliminated by 
the proteasome [188]. Ubiquitin independent degradation of oxidized proteins is further 
supported by the observation of reversibly disabled ubiquitin activating E1 enzymes and 
ubiquitin conjugating E2 enzymes during oxidative stress [189,190]. This fits very well 
with the observations that have been made in publication II, where 1h after treatment 
with H2O2 protein carbonyls reach a drastic increase, but protein ubiquitination remain 
at basal levels, indicating a low activity of the ubiquitination machinery (Publication II, 
Fig. 1C). Similar findings have been made for the 26S proteasome. After exposition to 
increasing concentrations of H2O2 it was observed that there is an overall decline in 
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detectable 26S proteasome activity, whereas the 20S proteasome remains largely 
unaffected [191,192]. In a recent published study from Grune et al. [193] it was shown, 
that there is no decline of 19S proteasome regulators during oxidative stress, but a 
dissociation of the 19S regulator from the 20S proteasome, captured and stabilized by 
Hsp70. Therefore it is suggested that the 19S regulator dissociates from the 20S 
proteasome to enhance the cellular capability to degrade oxidized proteins immediately 
after oxidative stress [194]. Moreover, lysine residues, which are the ubiquitin 
conjugation sites of proteins, are also prone for oxidative modifications, forming 2-
aminoadipic semialdehydes. 2-aminoadipic semialdehydes belong also to the group of 
protein carbonyls and are inadequate for ubiquitin conjugation, reducing the amount of 
free available ubiquitin conjugation sites [195]. Due to the inactivation of the 26S 
proteasome and the ubiquitin conjugating system during oxidative stress it seems 
unlikely that the ubiquitin-26S proteasome pathway deals with the degradation of the 
bulk of oxidized modified proteins. 
Due to an ubiquitin independent degradation of oxidized proteins by the proteasome, 
there must be another selection to enter the inner proteolytic core of the 20S 
proteasome. According to this, it was shown that there is a substrate degradation by 
isolated 20S proteasome upon incubation with hydrophobic tetra-peptides [196]. This 
was introduced by a peptide- induced opening of the α-ring due to the hydrophobicity of 
the peptides. Focusing on oxidized proteins, there is also an reported increase of 
hydrophobic moieties on protein surfaces after oxidative stress [197,198] (Fig.4.).  
 
Figure 4 Different stages of protein oxidation and proteasomal degradation 
Exposure of native proteins to an increasing amount of oxidative stress results in an ongoing 
unfolding process of the protein. Due to the protein unfolding the inner hydrophobic patches expose to 
the protein surface, functioning as signal for proteasomal degradation. Progressed unfolding of the 
protein leads to the formation of protein aggregates [199,200]. 
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In consequence of oxidative modifications of some functional groups of the amino acid 
residues, like disruption of disulfide bonds or intermolecular interactions because of 
protein carbonylation, proteins are a subject of an ongoing unfolding process. In regard 
to the oxidation related unfolding process, Jung et al. has summarized a theory where 
proteins can be categorized into three different stages, according to the progression of 
their oxidation- and unfolding status (Fig. 4) [201]. Exposure to very low concentrations 
of ROS/RNS results only in a slight oxidation of the protein. At this stage the protein 
possesses a reduced activity, but is fully intact. It should also be possible to reduce the 
protein damage at this stage by the effort of the mentioned thioredoxin TR(SH)
2
-
dependent methionine sulfoxide reductase. Further oxidation of the protein can induce a 
critical damage of the protein, resulting in a partial unfolding. Due to this unfolding 
process, hydrophobic amino acids that usually are hidden in the inner side of soluble, 
globular proteins expose to the outer protein surface. According to Jung et al. and many 
others this is an ideal state for recognition and degradation by the 20S proteasome [202-
205]. Heavy oxidation and unfolding of the protein increase its hydrophobicity and the 
probability for protein aggregation. Protein aggregates, such as lipofuscin, are no longer 
proper substrates for the proteasome and can even inhibit the proteasomal machinery 
[206]. Therefore, the proteolytic capability of the 20S proteasome to degrade oxidized 
proteins can be described like the curve of Figure 4. Slight oxidation of stage one does 
not require proteasomal degradation, but then with increasing oxidative modification, 
hydrophobicity and proteolytic degradation increase coincidently. At a critical point 
protein damage exceeds the proteolytic capability of the 20S proteasome, due to the 
formation of aggregates inhibiting the proteasome (Fig.4).  
In contrast, there is also limited evidence for the involvement of ubiquitin and the 26S 
proteasome in oxidized stress [207-209]. Most of this work was conducted by the group 
of A. Taylor with human lens cells. They also detected protein carbonyls and 
ubiquitinated proteins upon exposure to H2O2 [210,211]. Interestingly, they observed an 
augmentation of ubiquitinated proteins upon increasing concentrations of H2O2 and/or 
the application of LC. In further accordance with the results of Publication II/III they 
found the vast majority of ubiquitinated proteins at the high molecular weight region. 
Surprisingly, they determined only the total amount of protein carbonyls, ignoring the 
distribution/molecular weight of the carbonylated proteins [212] or if they show the 
molecular weight of the protein carbonyls, they only depict the high molecular weight 
region [213]. Hence, the interpretation of the results is difference. The group of Taylor 
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suggested a “common” participation of the 26S proteasome pathway, involving the 
preferential ubiquitination of oxidized proteins [214,215]. In contrast, interpreting the 
data from Publication II and III it has to be suggested that only a minority of proteins 
are ubiquitinated upon oxidative stress and most of these proteins are also ubiquitinated 
in unstressed cells such as Hsp90, Hsp70, Hsp60, actin, β-tubulin and vimentin, 
indicating no relationship to oxidative stress (Publication III). Maybe the elevation of 
ubiquitinated proteins upon H2O2 treatment is independent from the proteasomal 
system, but rather functioning as a signal for autophagy. 
4.4 The role of ubiquitin during proteotoxic stress and the maintenance of 
proteostasis 
The used stress stimuli in this work to introduce proteotoxic stress are H2O2/UV 
irradiation to induce oxidative stress and Lactacystin to inhibit the proteasome, leading 
to an unnatural accumulation of ubiquitinated proteins. As it is suggested and 
extensively discussed above, ubiquitin plays a minor role in the degradation of oxidized 
proteins. Nevertheless, there is an augmentation of ubiquitinated proteins in the later 
phase after treatment with H2O2 (Publication II and III). Additionally, there are some 
new identified ubiquitinated proteins upon H2O2 treatment compared to the control 
(Publication III). Interestingly, among these “H2O2-triggered” ubiquitinated proteins 
are the heterogeneous nuclear ribonucleoprotein U (hnRNP U), nucleolin or 
nucleophosmin. hnRNP U is a mRNA binding protein with regulating functions during 
the initial phases of the transcription by interaction with the RNA Pol II [216]. 
Nucleolin (also called C23) and nucleophosmin (also called B23) are two important 
multiple function proteins of the nucleus, participating in ribosome biogenesis, cell 
cycle regulation, chaperones of the nucleus and DNA repair [217,218]. Moreover, 
nucleophosmin has the ability to interact with both hnRNP U [219] and nucleolin [220]. 
Ubiquitination of these ribosomal associated proteins, especially of nucleophosmin, is a 
well known regulation mechanism [217,221]. The role of nucleophosmin ubiquitination 
and its cellular significance is not fully elucidated until yet. Although, ubiquitinated 
nucleophosmin is a substrate for proteasomal degradation, it is reported that 
ubiquitination can also result in increased protein stability of nucleophosmin [222]. 
Furthermore, it is suggested that K63-linked ubiquitination of ribosomal associated 
proteins regulates the translation efficiency of ribosomes [223]. Because nucleolin and 
nucleophosmin are two abundant proteins, the consequences of their ubiquitination are 
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only speculative and not clear at present. However, it seems obvious that ubiquitination 
of such proteins upon oxidative stress are a fine tuned, regulative mechanism and no 
random degradation mechanism of some oxidative proteins. Certainly it is thinkable that 
ubiquitination after 8h, 16h or 24h after oxidative stress serves to degrade the up-
regulated stress response proteins in the cytosol and in the nucleus in a controlled and 
regulated manner.  
Inhibition of the proteasome, as it was used in Publication II-IV, is automatically 
associated with the accumulation of undegraded, polyubiquitinated proteins. 
Accumulation of polyubiquitinated proteins leads to proteotoxic stress and acts 
coincidently as a multivariable signal, initiating a number of response mechanisms that 
cope with proteasomal inhibition. Increasing masses of polyubiquitinated proteins tend 
to form larger protein aggregates if proteasomal inhibition remains not responded or last 
over a longer period of time [224,225]. Since the amount of (mono-) ubiquitin 
molecules is limited in the cell, there is a shortage of free available ubiquitin molecules 
after or during proteasomal inhibition. Moreover, the reduction of free available 
ubiquitin in the cytoplasm results in a shift of ubiquitin between the two major ubiquitin 
pools. Due to the lack of available ubiquitin in the cytoplasm there is an observed 
redistribution of ubiquitin from the nucleus to the cytosol, accompanied by a coincident 
deubiquitination of histones [226,227]. Besides acetylation and methylation, 
ubiquitination is a major regulator of histone function. In mammalian cells 
ubiquitination is mainly found on the histones H2A and H2B which is associated with 
condensed DNA, gene silencing, regulation of RNA polymerase II and transcription 
regulation [228-230]. Thus, it is suggested that histone deubiquitination and the 
accompanied activation of gene expression is a calculated response to the proteotoxic 
stress of proteasome inhibition. 
In addition, the accumulated polyubiquitinated proteins function as signal which can be 
detected by HDAC6, resulting in the activation of several response mechanisms: (i) 
stabilization and prevention of aggregate formation by the induction of classical Hsps, 
(ii) elimination of polyubiquitinated proteins/aggregates by HDAC6 mediated 
aggresome formation and autophagy, (iii) containment of inflammation by the induction 
of HO-1 and Nrf-2 pathway and (iv) reduction of proteotoxic stress mediated apoptosis  
by the induction of classical Hsps and HO-1 (Publication IV) [231-233] (Fig. 5). The 
particular effects and mechanisms of HDAC6, Hsps and HO-1 are discussed in detail in 
the following chapters below.  
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4.5 The role of heat shock proteins during proteotoxic stress 
In unstressed situations protein homeostasis is balanced by the controlled degradation of 
proteins by the proteasome as well as the folding and stabilization of proteins by the 
constitutive expressed chaperones of the Hsp family [234]. In stress situations, affecting 
proteostasis, it is absolutely indispensible that the particular preservers of proteostasis 
have the ability to adapt by increasing their activity or their total amount. Concerning 
Hsps, there is a drastic increase of several Hsps, highly regulated and initiated by 
inducible HSF-1 or in case of HO-1 induction by Nrf-2 [235,236] (Publication IV). 
Proteotoxic stress can be evoked for example by heat shock, oxidative stress or 
proteasome inhibition, resulting in an accumulating mass of unfolded/misfolded, 
ubiquitinated, aggregated and unfunctional proteins which jeopardize cell viability. In 
case of proteasome inhibition, which is the stress stimulus in Publication IV, there is in 
accordance with previous studies an up-regulation of Hsp27, Hsp70 and HO-1 mRNA 
and proteins (Publication IV) [237-241]. Although it seems evident that there is a 
responsive induction of chaperones, the kinetic of this induction varies between 
different cell lines and species. In the chicken erythoblastic cell line HD6 Hsp70 
induction reaches its peak already after 2 and 4 hours upon proteasome inhibition with 
MG132 [242], whereas inhibition with Lactacystin in xenopus laevis A6 cells, induction 
of Hsp70 and 30 was significant elevated after 12 hours [243]. The latter is in 
accordance to the results of Publication IV, suggesting a dependency to the given 
proteasome inhibitor and cell line. Elevation of HO-1 seems also to be a slower 
response, due to its first significant up-regulation after about 12 to 48 hours [244,245] 
(Publication IV). 
The general effects of HO-1 activity can be divided into two major parts: its 
antioxidative properties and the anti-inflammatory/anti-apoptotic properties. Although 
the increase of oxidative stress upon proteasome inhibition is limited, which is 
demonstrated by DCF assay in Publication IV (Publication IV), and seems not to be the 
major reason for HO-1 induction, the anti-oxidative effects are also important during 
proteasome inhibition. HO-1 oxidizes with the help of NADPH cytochrome P450 
reductase free heme to biliverdin, free Fe
2+
 and CO [246,247]. Fe2+, which is itself a 
reactive inducer of ROS by the involvement of the Fenton Reaction [118], induces the 
expression of antioxidative ferritin. Biliverdin is immediately reduced to bilirubin, 
functioning verifiable as a scavenger of ROS and RNS[248-250]. The anti-apoptotic 
effect and anti-inflammatory effect are mainly mediated by the liberation of CO. CO 
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acts as a second messenger, reducing the expression of pro-inflammatory cytokines such 
as TNF-α, IL-1β, MIP-1β. On the other side CO mediates the up-regulation of IL-10 
prolonging cell survival [251]. Moreover, there are some evidence that HO-1 related 
augmentation of CO inhibit p53 dependent cell death and the release of cytochrome C 
[252,253]. Recent findings demonstrated that p53 is a major factor of proteasome 
inhibition dependent apoptosis [254,255]. Because p53 is also a substrate of the UPS, 
p53 accumulates in the nucleus upon proteasome inhibition resulting in apoptotic cell 
death. Moreover, Latonen et al. demonstrated that ubiquitin is necessary to transfer p53 
between nuclear and cytosolic compartments, resulting in a nuclear accumulation of p53 
in the nucleus when there is a lack of free available ubiquitin during proteasomal 
inhibition [256]. Therefore, HO-1/CO mediated interaction with p53 is a regulating 
counterpart to the p53 mediated apoptosis upon proteasome inhibition.  
The suggested regulation pathway in Publication IV, where HO-1 is induced by Nrf-2 
and p38MAPK activation is in accordance with some other studies (Publication IV). 
Wu et al. [257] also found evidence for the involvement of activated p38MAPK in HO-
1 up-regulation upon proteasome inhibition. Using SB203580 as a p38MAPK inhibitor, 
HO-1 induction reaches after proteasome inhibition only the same levels than the 
untreated controls [258]. In another study treating cells with proteasome inhibitors, it 
was shown that cellular Nrf-2 content is augmented and Nrf-2 is needed for the up-
regulation of HO-1 upon proteasome inhibition [259]. The latter was confirmed by the 
co-transfection of transgenic KEAP-1 in combination with proteasome inhibition, 
resulting in a significant decrease of ARE-dependent genes, including HO-1 [260].  
Focusing on oxidative stress, HO-1 is a very important cellular antioxidative defense 
mechanism, diminishing ROS and the resulting oxidative stress. Hence, cells lacking 
HO-1 or possess inhibited HO-1 activity, exhibit greater ROS concentrations and tend 
more to undergo cell death [261,262]. Interestingly, in Publication III major 
representatives of classical Hsps (Hsp60/70/90) have been found in the ubiquitin 
fraction, but HO-1 was not ubiquitinated. This fact leads to some suggestions: either 
HO-1 is degraded in an ubiquitin independent way, HO-1 has been degraded much 
quicker than 16h and does not appear in the ubiquitin fraction after16h, HO-1 is not 
degraded due to its importance in the antioxidative defense mechanism or HO-1 content 
in the ubiquitin fraction was too low for its determination. Due to the fact that HO-1 is 
an ER-membrane located protein, it is normally degraded by the ubiquitin-proteasome 
dependent ERAD process [263], which disproves the suggestion that HO-1 is not a 
Discussion 
_____________________________________________________________________________ 
104 
 
substrate for ubiquitination. Further on, in Publication III melanoma cells were also 
treated with LC inhibiting proteasomal degradation, resulting in the accumulation of all 
ubiquitinated proteins over the period of 16h. Thus, if HO-1 is ubiquitinated during that 
time, it had to be detected in that fraction, which was obviously not the case 
(Publication III). Therefore it must be assumed that HO-1 is not ubiquitinated during 
(oxidative) stress situations to help keeping up cell homeostasis, function and survival. 
Certainly it is possible that HO-1 was not detected in the ubiquitin fraction because of a 
too low protein content of HO-1 in this fraction, however, this seems very unlikely due 
to the high induction of HO-1 during stress conditions (Publication IV) [264-266] and 
the mentioned accumulation of UPS substrates in LC treated cells. 
 
The role of the classical Hsps during proteotoxic stress is a little bit different compared 
to HO-1. The observed up-regulation of Hsp27 and Hsp70 in Publication IV, initially 
provoked by the accumulated amount of ubiquitinated proteins, seems to be a 
compensational attempt of the cell to cope with the emerging amount of unfolded 
proteins. Increasing amounts of unfolded (polyubiquitinated) proteins, also augment the 
likelihood of the formation of protein aggregates, which can occur after proteasome 
inhibition or oxidative stress [267]. Protein aggregates are toxic, disrupt cell 
functionality and can lead finally to cell death. Thus, formation of protein aggregates 
correlates with the occurrence of several age-dependent diseases, such as 
neurodegeneration [268], AMD [269], cataracts [270], skin ageing [271] and 
atherosclerosis [272] (Publication I). Preventing protein aggregation is therefore one 
major task of Hsps. Especially the observed up-regulated Hsps 27 and 70 are crucial in 
the disaggregation process. It was shown by the group of Liberek that Hsp70 is the 
chaperone that participates in the initial step of disaggregation by disentangle 
polypeptides from aggregates [273,274]. Moreover, there is evidence that small Hsps 
(sHsps) support the disaggregation reaction of Hsp70 by their incorporation in high 
molecular protein aggregates. Thus, sHsps loosen the aggregate structure and make the 
incorporated polypeptides more susceptible to Hsp70 mediated disaggregation 
[275,276]. The co-localization of small Hsps with several cellular proteins such as actin- 
and intermediate filaments, ubiquitin ligases, DNA-binding proteins, HO-1 and 
proteasomal subunits after stress, elucidate the importance of sHsps in their function to 
keep proteins in a soluble confirmation [277]. It is suggested that about 33% of all 
cytosolic proteins retain in a soluble state by the help of sHsps in yeast [278]. 
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In many organisms (bacteria, yeast, plants) Hsp70 transfer the disentangled polypeptide 
to the Hsp104/CIp machinery, which is a high molecular weight Hsp trying to refold the 
aggregated polypeptides [279]. For a long time there was no evidence for such a 
disaggregase in mammalian cells. p97/VCP, being also a part of the complex with 
HDAC6, Hsp90 and HSF-1 (Publication IV) [280], has shown to collaborate with 
Hsp70 and Hsp40 to refold soluble misfolded proteins and prevent protein aggregation 
[281]. However, there was no convincing demonstration of p97- catalyzed 
disaggregation using pure components [282]. In a recent published work from Shorter et 
al. [282] it was indicated that cell lysates from rat liver as well as from HeLa cells have 
the ability to disaggregate protein aggregates. Moreover, it was demonstrated that this 
disaggregase activity is mediated by the constitutive form of Hsp110 – Apg2 [282]. In 
this model Hsp110 interacts with Hsp70 and Hsp40, forming a disaggregase machinery, 
which is comparable to the yeast model. Although, the Hsp110- dependent disaggregase 
was able to disaggregate disordered, amorphous aggregates, it failed to catalyze the 
reduction of amyloids, suggesting that such aggregates have to be removed by 
autophagy [282].  
Like HO-1, Hsp27 and Hsp70 have also anti-apoptotic properties when they are up-
regulated. Hsp70 prevents apoptosis by inhibition of the apoptosis inducing factor 
(AIF), formation of the apoptosome and prevention of caspase 3 activation [283]. Hsp27 
prevents the release of cytochrome c, interacts also with caspase 3 and is involved in the 
degradation of I-κBα, resulting the activation and translocation of NF-κB and thus in 
increased cell survival [284,285]. Further on, it was shown that Hsp27 possesses an 
ubiquitin binding domain and is able to enhance the activity of the 26S proteasome by 
its chaperone domain [286]. This would be of special interest for newly synthesized 
proteasomes to cope with the accumulated mass of ubiquitinated proteins after 
proteasome inhibition. In regard to this, Hsp70 has also the ability to support the UPS 
when it has recovered. Like it was mentioned in the introduction and in Fig. 2, Hsp70 is 
together with its co-chaperones Bag-1 and CHIP involved in the ubiquitination of 
unfolded proteins and their transport to the proteasome, enhancing the efficiency of the 
UPS. 
The role of the classical Hsps during and after oxidative stress is indifferent and a 
broadly discussed topic. As it is shown in Publication III, there is a reduction of Hsp70 
and Hsp90 immediately after the treatment with H2O2. Not until 16h after the treatment 
with H2O2, protein levels of Hsp70 and Hsp90 remain under the protein levels of the 
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untreated controls. Due to the fact that Hsps are high inducible upon proteotoxic stress 
this is a surprising result. Maybe it is a matter of the used cells and the source producing 
ROS. Wallen et al. treated cells with heat, menandione, H2O2 and a xanthine/xanthine 
oxidase system. Only heat stress and the treatment with menandione led to an induction 
of Hsp70, but not the treatment with H2O2 and xanthine/xanthine oxidase [287]. In 
accordance to this Adachi et al. also failed to induce Hsp70 with H2O2. Treatment with 
0.25mM H2O2 for 1h, 2h and 5h resulted in no induction of Hsp70 [288]. Moreover, 
treatment with 44°C for 20min together with H2O2 led to a much lower Hsp70 protein 
content than heat treatment alone, indicating a H2O2 induced degradation of Hsp70 or a 
disrupted induction via HSF1 [288]. Therefore it can be suggested that oxidative stress 
leads to no induction of Hsp70 or Hsp90 (at least not in the first hours after the cell 
treatment), but rather to a degradation of the two Hsps. Like it was already mentioned 
most oxidative protein modifications are irreversible and the affected proteins have to 
be degraded by the proteasomal system. Thus, Hsp70 or Hsp90 are unable to 
repair/refold these modified proteins during the acute phase during and after oxidative 
stress. However, in Publication III it is observed that Hsp70 and Hsp90 recover 16h 
after H2O2 treatment. In this late phase after oxidative stress, it can be supposed that 
Hsp70 and Hsp90 are needed to support the ubiquitin dependent degradation of proteins 
and disaggregate oxidative stress mediated protein aggregates. The reason for the 
degradation of the two chaperones during the “first phase” after H2O2 treatment is 
unclear. One thinkable reason is an oxidative mediated damage of the chaperones, 
resulting in their proteasomal degradation. 
4.6 The role of HDAC6 in maintenance of protein homeostasis 
Since HDAC6 was identified as an unusual histone deacetylase, possessing two 
catalytic domains, an ubiquitin binding domain and a preferred localization in the 
cytosolic compartment, it was shifted into the focus of posttranslational protein 
modification and regulation [289]. Recent findings show evidence that HDAC6 
mediates the removal of misfolded proteins and favors their accumulation into cellular 
aggresomes by interaction with ubiquitin and dynein motors. HDAC6 has the ability to 
bind coincidently to ubiquitinated proteins via the BUZ domain (also called ZnF-UBP 
domain [290]) and to the dynein motor component p150
glued
 via a DMB domain, 
functioning as a linker between ubiquitinated proteins and the tubulin-dynein-motor 
system [291]. Because HDAC6, lacking its catalytical domain failed to rescue 
aggresome formation and tubulin is a major target of HDAC6 deacetylation, it is 
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suggested that HDAC6 also facilitates the transport of the dynein-misfolded-complex to 
the aggresome by deacetylation of microtubules [292]. Aggresomes are inclusion bodies 
next to the nucleus at the proximity end of the microtubule organizing center. 
Aggresomes are the endpoint of the microtubule dependent transport of 
polyubiquitinated protein aggregates, degrading long lived cytosolic proteins, overload 
or damaged cytoplasmatic organelles and damaged, abnormal protein aggregates [293]. 
Further support of the role of HDAC6 in autophagy, was demonstrated by the direct 
dependency on HDAC6 for the autophagic clearance of CFTR [294] or mutant 
Huntingtin aggregates [295] and the HDAC6 mediated recruitment of the autophagic 
machinery to aggresomes [296].  
Furthermore, Boyault et al. demonstrated that HDAC6 related polyubiquitin binding 
acts as a “masking function”, hampering the interaction with other ubiquitin binding 
factors like USPs or proteasomal subunits [297]. As a consequence HDAC6 has the 
ability to reduce the polyubiquitin turnover, which would lead to an attenuation of 
ubiquitin- proteasomal degradation and an excessive accumulation of polyubiquitinated 
protein aggregates in aggresomes. To keep the balance of the fate of polyubiquitinated 
proteins, HDAC6 interacts with the AAA-ATPase chaperone p97/VCP [298]. p97/VCP 
plays an important role in the preparation and transport of polyubiquitinated proteins to 
the proteasome and dissociates the HDAC6-ubiquitin complex, counteracting the 
HDAC6 promoted accumulation of polyubiquitinated in aggresomes and support their 
degradation by the proteasome. Thus, the HDAC6-p97/VCP complex is a crucial 
regulator of the cellular fate of misfolded-polyubiquitinated proteins. Dissociation of 
HDAC6 from p97/VCP, liberates HDAC6 for the binding of new polyubiquitinated 
proteins and its interaction with other substrates [299,300].  
Besides the involvement in autophagy and aggresome- related degradation of 
polyubiquitinated proteins, HDAC6 and its connection to p97/VCP is also a crucial 
factor for the up-regulation of heat shock proteins upon proteasome inhibition. In 
another study Boyault et al. used different HDAC6 mutant/knockdown cell lines to 
examine the involvement of HDAC6 in the induction pathway of classical heat shock 
proteins [301]. In absolute accordance to the results of Publication IV, they revealed 
that HDAC6 presence is absolutely essential for the up-regulation of heat shock proteins 
upon proteasomal inhibition. Same observations have been made by RNAi mediated 
suppression of HDAC6 (Publication IV, Fig. 3) Moreover, it seems that the ubiquitin-
binding domain is also essential for the observed Hsp induction, due to the fact that cell 
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possessing a mutant HDAC6 with an unfunctional ubiquitin binding domain also have 
no Hsp induction upon proteasome inhibition [302]. This could also be confirmed by 
suppression of ubiquitin activating enzymes E1, resulting as well in a clear attenuation 
of Hsp induction after LC treatment (Publication IV, Fig. 3). Deacetylase activity of 
HDAC6 seems to play no role in Hsp induction, due to the fact that cell lines with 
HDAC6 deficient catalytic domains show also a clear induction of Hsps after 
proteasome inhibition. Further on, they found evidence for a complex formed out of 
Hsp90, HSF-1, p97/VCP and HDAC6. In case of proteasomal inhibition there is a 
consequent accumulation of ubiquitinated proteins, which are sensed by the ubiquitin-
binding domain of HDAC6. Binding of ubiquitinated proteins induces the dissociation 
of the HDAC6-p97/VCP complex [303-305]. Following the liberation of HDAC6 and 
p97/VCP, the latter uses either its ATP dependent segregase activity to dissolve the 
bond between Hsp90 and HSF-1 directly or p97/VCP stimulates the Hsp90 ATPase 
activity, which results in the release of HSF-1 and the consequence up-regulation of 
several heat shock proteins [306]. Thus, ubiquitin is a strong regulator of HDAC6-
p97/VCP interaction and the related cell response.  
 
Figure 5: Role of HDAC6 in the maintenance of protein homeostasis. 
Proteasome inhibition leads to the accumulation of polyubiquitinated proteins. These were sensed by the 
ubiquitin binding domain of HDAC6. Binding of HDAC6 leads to the dissociation of a complex, made 
out of HDAC6, p97/VCP, Hsp90 and HSF-1. Unbound HSF-1 trimerizes and functions as an activating 
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transcription factor for classical Hsp. HDAC6 initiates the formation of aggresomes and the autophagic 
clearance of ubiquitinated protein aggregates. HDAC6 is also needed for the p38/Nrf-2 dependent 
activation of HO-1 by the deacetylation and indirect activation of p38. Hsp90 functions also as molecular 
chaperone, supporting protein folding and stabilization.  
 
Beyond the up-regulation of classical Hsps upon proteasome inhibition, it is 
demonstrated in Publication IV, that HDAC6 is also involved in an induction of HO-1 
after proteasome inhibition (Publication IV). Initiation of this pathway is also the 
detection of ubiquitinated proteins and the release of HDAC6. Previous studies could 
show that the induction of HO-1 upon proteasome inhibition is mediated by a 
p38MAPK-dependent activation of Nrf-2, which is the most important transcriptional 
activator of HO-1 gene translation [307]. In Publication IV it is demonstrated for the 
first time that p38 is a substrate for HDAC6 mediated deacetylation, and this 
deacetylation step is necessary for p38 phosphorylation and thus for the activation of 
Nrf-2 and HO-1 (Publication IV). There is only limited knowledge about the 
acetylation/deacetylation of p38. In a paper from Shin et al. application of the unspecific 
HDAC class I and II inhibitor Trichostatin (TSA), results in a diminished 
phosphorylation/activation of p38 [308]. Contrarily in a publication stimulating mouse 
macrophages (RAW 264.7) with the bacterial endotoxin lipopolysaccharide (LPS), 
HDAC6 seems to attenuate the phosphorylation of p38, while repression of HDAC6 via 
siRNA results in an augmentation of phosphorylated p38 after LPS stimulation. 
However, comparing with the control siRNA the results seems to be inconclusive [309].  
Summarized HDAC6 is an essential regulator of protein homeostasis, functioning as a 
sensitive sensor for the status of ubiquitinated proteins in the cellular system. Due to its 
involvement in the initiation of aggresome formation and autophagic clearance of 
ubiquitinated aggregates as well as the induction of classical Hsps and HO-1, HDAC6 
plays a major role in the degradation of ubiquitinated damaged proteins, stabilization of 
misfolded/unfolded proteins and prevention of cell death [310-314] (Fig. 5)  
 
4.7 HDAC6 and the proteasome in cancer  
Due to the central part of the proteasome in the maintenance of proteostasis, it is also a 
promising target for cancer therapy. Inhibition of the proteasome by the FDA-accepted 
proteasome inhibitor bortezomib has successfully been tested for multiple myeloma 
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(MM) in several clinical studies [315-317]. Inhibition of NF-κB activation, inhibition of 
myeloma cell adherence and the accumulation of toxic, polyubiquitinated, 
unfolded/misfolded proteins have been proposed as possible mechanism of action [318]. 
At the moment bortezomib is also tested for the therapy of other solid tumors, such as 
lung cancer or prostate cancer [319,320]. 
However, it is frequently reported that there are many cancer cells exhibiting a 
resistance against bortezomib treatment with the result of diminished treatment success. 
Induction of heat shock proteins or makroautophagy are two major reasons for the 
resistance of cancer cells against proteasome inhibition [321,322]. Chauhan et al. 
demonstrated in human SUDHL lymphoma cells by inhibition of Hsp27, using Hsp27 
antisense RNA, increased apoptosis after treatment with bortezomib [323]. Moreover, in 
a review from Wu et al. [324] it is precisely explained that there are several pathways 
inducing compensating makroautophagy upon proteasome inhibition, diminishing the 
efficiency of bortezomib treatment. Makroautophagy as well as the up regulation of heat 
shock proteins prevent the unfolded protein response in the endoplasmatic reticulum 
and subsequent apoptosis by the compensating degradation, folding or stabilization of 
unfolded, polyubiquitinated proteins and toxic aggregates. A key player in the 
regulation of these two response mechanisms is HDAC6 [325,326] (Publication IV). 
Since it is demonstrated in Publication IV, that HDAC6 is also involved in the 
induction of HO-1, which also contributes to the anti- apoptotic response to proteasome 
inhibition, HDAC6 should be an interesting target for a combined treatment with 
bortezomib in cancer therapies. This could be of particular interest in tumors 
overexpressing HDAC6. Because HDAC6 is an estrogen regulated gene [327] the 
deacetylase is drastically overexpressed in estrogen-dependent breast cancer, but also in 
squamous cancer cell lines or ovarian carcinomas [328]. Besides the induction of 
proteotoxic response mechanisms, HDAC6 is also crucial for oncogenic transformation 
of cancer cells. Results from Lee et al. strongly indicate the requirement of HDAC6 for 
Ras-induced oncogenic transformation by providing anchorage-independent 
proliferation of cancer cells, which is a hallmark of malignant transformation [329]. 
Interestingly, in this study HDAC6 knockdown shows a significant decrease in 
phosphorylation of AKT and ERK1/2, supporting the thesis that HDAC6 has the ability 
to interact with kinases of the MAPK pathway. 
Thus, specific HDAC6 inhibitors, like Tubacin or its derivative NK84, were developed 
and successfully evaluated for its antitumor activity in several cancer types, such as 
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MM, lymphoblastic leukemia, pancreatic cancer, lung cancer or breast cancer 
[330,331]. Combined treatment of ovarian cancer cells with bortezomib and the specific 
HDAC6 inhibitor NK84 resulted in a drastic decrease of cell viability compared to 
single bortezomib treatment. Moreover, combined treatment allows much lower 
bortezomib concentrations to achieve equal outcomes [332]. Increased amounts of 
ubiquitinated proteins, decreased cell motility and migration after cell scratching 
experiments and the increase of apoptotic markers like PARP cleavage indicate the 
augmentation of proteotoxic stress, leading to increased cell death of cancer cells upon 
combined treatment with bortezomib and Tubacin/NK84. Similar results have been 
made for MM and pancreatic cancer cells after combined treatment with bortezomib and 
Tubacin [333,334]. Due to the fact that high dose bortezomib therapy leads to different 
stages of neuropathies as a side effect, combined treatment with Tubacin would allow to 
lower bortezomib concentration, which would demonstrably reduce neuropathy during 
and after the cancer therapy [335].  
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5. Conclusion 
Maintenance of protein homeostasis is crucial for keeping up cell functionality and cell 
viability. The ubiquitin proteasomal system as well as HDAC6 are two components of 
the maintenance system to keep up protein homeostasis. The aim of this work was to 
elucidate the role of these systems during several stress situations, in particular the 
responsibility of the ubiquitin proteasome system during oxidative stress and the stress 
response mechanisms during and after proteasome inhibition.  
As a result following points can be summarized:  
 Oxidative stress leads to increased amounts of oxidized proteins and 
ubiquitinated proteins. However, it becomes obvious that most oxidized proteins 
are not ubiquitinated after oxidative stress 
 By isolation of ubiquitinated proteins before and after oxidative stress and 
following determination of these proteins by MALDI-TOF mass spectroscopy it 
can be suggested that ubiquitination after oxidative stress is a regulative 
mechanism and affects only distinct proteins, e.g. Hsps or regulative nuclear 
proteins 
 Inhibition of the proteasome results in a compensative induction of classical 
Hsps, such as Hsp27 or Hsp70 and the stress response proteins HO-1 
 Induction of these stress response proteins is mediated by an accumulating mass 
of ubiquitinated proteins and its detection by HDAC6 
 The HDAC6 dependent induction upon proteasome inhibition of classical Hsps 
is mediated by Hsf-1 
 HDAC6 dependent induction upon proteasome inhibition of HO-1 is mediated 
by an p38MAPK/Nrf-2 pathway 
 Activation of p38 is mediated via direct deacetylation of p38 by HDAC6 
In regard to these results it is obvious that both, the UPS as well as HDAC6, are two 
major players of the cellular stress response. Especially HDAC6 has the ability to 
induce several different stress response mechanisms to cope with increasing proteotoxic 
stress levels. Knowing the stress response mechanism upon proteasome inhibition 
reveals for example new targets to overcome proteasome inhibitor resistance in cancer 
therapy.  
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7. Abstract/Zusammenfassung 
7.1 Abstract 
The control and maintenance of protein homeostasis is a crucial factor to maintain cell 
functionality, cell viability and cell division. To cope with this challenge the cell obtain 
a large variety of repair- and stabilization proteins, meaning especially the family of 
heat shock proteins, as well as proteases such as the ubiquitin proteasomal system 
(UPS), which degrades defect, modified, unused and irreparable proteins. There are 
different kind of stress stimuli, disturbing protein homeostasis and therefore the entire 
cell physiology. In this work cells were stressed with hydrogen peroxide (H2O2) to 
generate oxidative stress or Lactacystin to inhibit the proteasome. For both cases the 
role of the UPS was investigated. Additionally, it was elucidated which compensatory 
mechanisms are activated when the proteasome is inhibited. 
Methodical this comprises the isolation of proteins via different immunoprecipitation 
techniques, the identification of the proteins by MALDI-TOF mass spectrometry and 
diverse immunoblotting techniques, gene silencing of distinct gene/proteins by siRNA 
transfection, different protein activity assays and RT-qPCR to verify the expression at 
mRNA levels. 
As a result it is shown that after treatment with H2O2 most oxidized proteins are not 
ubiquitinated. Although, there is an increase of ubiquitinated proteins 16h after H2O2 
treatment, it can be suggested due to the mass spectrometry results that ubiquitination 
upon proteasome inhibition is a regulatory mechanism affecting only distinct proteins 
and not the bulk of oxidized proteins. 
After inhibition of the proteasome there is also a drastic accumulation of ubiquitinated 
proteins. The accumulating mass of undegraded, ubiquitinated proteins acts as a marker 
or signal for proteotoxic stress. Interaction of ubiquitinated proteins with the 
histondeacetylase 6 (HDAC6), results in the compensatory up-regulation of several 
chaperones/Hsps and heme oxygenase-1 (HO-1). Induction of Hsps is mediated by a 
HDAC6 dependent release of the heat shock factor 1 (HSF1). Induction of HO-1 is 
mediated by a p38MAPK/Nrf-2- dependent pathway, whereas p38 is directly 
deacetylated by HDAC6 upon proteasome inhibition. Deacetylation of p38 prepares the 
kinase for further phosphorylation and activation. Up-regulation of Hsps and HO-1 
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upon proteasome inhibition stabilizes ubiquitinated proteins, reduces the risk of 
aggregation and function as well anti-apoptotic, anti-inflammatory and anti-oxidative. 
 
Due to these results it can be suggested that the UPS and HDAC6 play a central role in 
the maintenance of protein homeostasis and function as an essential connection to the 
down-stream located stress response mechanisms. 
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7.2 Zusammenfassung 
Die Kontrolle und Aufrechterhaltung der Protein-Homöostase ist ein wichtiger Beitrag 
zum Erhalt der Zellfunktion, Zellvitalität und der Zellteilung. Um diese Aufgabe zu 
erfüllen besitzt die Zelle ein breites Spektrum an Reparatur- und Stabilisationsproteinen, 
allen voran die stressinduzierbaren Hitzeschock Proteine (Hsps), sowie multi-
katalytische Proteasen, wie das Proteasom, die zum Abbau defekter, veränderter, nicht 
mehr gebrauchter und irreparabler Proteine beitragen. Verschiedene Arten von Stress 
sind in der Lage die Protein-Homöostase aus dem Gleichgewicht zu bringen und somit 
auch die allgemeine Zellphysiologie zu stören. In der hier vorliegenden Arbeit wurde 
der zelluläre Stress zum einen durch Hydrogenperoxid-induzierten Oxidativen Stress 
zugefügt und zum anderen durch die Inhibition des Proteasoms mittels Lactacystin. In 
beiden Fällen wurde die Rolle des Proteasoms als auch die der Ubiquitinierung 
untersucht. Zusätzlich wurde herausgearbeitet welche alternativen und 
kompensierenden Mechanismen aktiviert werden, wenn das Proteasom gehemmt ist. 
Methodisch beinhaltet dies, Proteine und deren Expression auf vielfältigste Weise zu 
untersuchen: Isolation verschiedener Proteine aus verschiedenen Zelllinien mittels 
unterschiedlicher Immunoprezipitations-Techniken, die Identifizierung der isolierten 
Proteine mittels MALDI-TOF-Massenspektroskopie, verschiedene Immunoblott-
Techniken, das Blockieren von Genen/Proteinen durch den Einsatz von RNAi-
Techniken, verschiedene Aktivitätstest einzelner Proteine sowie die 
Expressionskontrolle der mRNA ausgesuchter Proteine.  
Als Resultat konnte gezeigt werden, dass nach oxidativem Stress ein Großteil der 
oxidierten Proteine nicht ubiquitiniert wird. Obwohl sich 16h nach oxidativem Stress 
ebenfalls ein Anstieg von ubiquitinierten Proteinen zeigt, kann aufgrund der 
massenspektroskopischen Analyse davon ausgegangen werden, dass es sich hierbei um 
gezielte, regulatorische Ubiquitinierungen handelt.  
Durch Inhibition des Proteasoms kommt es ebenfalls zu einer drastischen Akkumulation 
von polyubiquitinierten Proteinen. Die Akkumulation von ubiquitinierten Proteinen 
kann als Marker oder Signal für proteotoxischen Stress angesehen werden. In einem 
Histondeacetylase 6 (HDAC6) abhängigen Schritt führt die Detektion der 
akkumulierten ubiquitinierten Proteine zu kompensatorischer Induktion von 
verschiedenen Chaperonen und der Hämoxygease- 1 (HO-1). Die Induktion der Hsps 
erfolgt über die HDAC6 gesteuerte Freisetzung des Hitzeschock-Faktor 1 (HSF1). Über 
einen p38MAPK/Nrf-2 abhängigen Signalweg kommt es zur Induktion der HO-1, 
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wobei dabei p38 direkt durch die HDAC6 deacetyliert und somit aktivierbar wird. Die 
Zunahme an Hsps und der HO-1 trägt zu Stabilisierung der ubiquitinierten Proteine bei, 
vermindert deren Aggregation und wirkt anti-apoptotisch, anti-inflammatorisch und 
anti-oxidativ. 
Durch die vorliegenden Ergebnisse lässt sich schlussfolgern, dass das Ubiquitin-
Poteasomale-System und die HDAC6 eine zentrale Rolle in der Aufrechterhaltung der 
Proteinhomöostase einnehmen und als wichtige Knotenpunkte für die weitere 
kompensatorische Stressantwort fungieren.  
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